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“We are born for co-operation as are the feet, the hands, 
                                            the eyelids and the upper and lower jaws.”
     Marcus Aurelius 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         To Ilkka, Mikaela and Oliver
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ABSTRACT 
 
The aim of this study was to investigate oral health characteristics and findings, clinical and 
radiographic findings of the TMJ, and the association between HLA antigens in patients with 
different rheumatic diseases. 
 
Study design: A cross-sectional study was carried out between 1996 and 1998. Eighty six 
patients (25 with rheumatoid arthritis (RA), 19 with mixed connective tissue disease (MCTD), 
20 with ankylosing spondylitis (AS), 22 with spondyloarthropathy (SPA) and 86 age- and sex 
-matched controls participated in the study. They were clinically examined and all filled in a 
questionnaire for oral- and temporomandibular disorders (TMD). Unstimulated and 
stimulated salivary flow rates were measured. Selection of salivary proteins and 
immunoglobulins were analysed. In addition patients underwent minor salivary gland biopsy, 
panoramic- and lateral panoramic radiographs and MRI of TMJ were obtained. HLA alleles 
(A, B, C and DRB1*) analysis was performed.  
 
Results: Focal sialadenitis was observed in 68% (57/84) of all patients. It affected 80% 
(20/25) of the RA, 94% (17/18) of the MCTD, 58% (11/19) of the AS, and 41% (9/22) of the 
SPA patients (p=0.0013). Secondary Sjögren’s syndrome (SS) was diagnosed in 31% of the 
patients. It was most frequent (73%) in MCTD and least frequent (15%) in SPA patients. 
Salivary secretion correlated negatively with the focus scores, i.e. severity of focal 
sialadenitis. In all patients salivary albumin, total protein, IgG, and IgM concentrations were 
higher than in controls. Oral yeast counts were significantly higher in the patients than in 
controls (p<0.001). Severe periodontitis (CPI 3-4) existed more often in the patient groups 
than in control subjects. Patients with rheumatic diseases reported severe TMJ symptoms 
significantly more often than control subjects (p<0.001). 
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 Mean maximum opening of the (SD) was significantly less in patients with rheumatic disease 
(46.3 [8.6] mm than in control subjects (55.0 mm [7.4] mm; p<0.001) mouth. 
 Marked erosions in TMJ by panoramic tomography were observed in all rheumatic groups, 
but most often in SPA (38%) and AS patients (37%). The existence of erosion was associated 
with evidence of restricted movement of condyle in panoramic radiographs (p<0.001). There 
was correlation between radiographic findings relating to the TMJ and subjective and clinical 
symptoms of temporomandibular disorders (TMD) in patients with rheumatic diseases.  
 
MRI showed many changes in TMJ ie. condylar changes including erosion, osteophytes and 
abnormal shape, and disc alterations including perforation, abnormal anterior position, as well 
as decreased movement. These abnormalities were most frequent in RA patients, and least 
frequent in MCTD and SPA patients. Reduced maximum opening of the mouth correlated 
with abnormalities of the disc and articular cartilage in MRI. Severe condylar erosion in 
panoramic tomography was significantly associated with MRI findings. In the whole patient 
population, HLA-DRB1*01 allele was significantly associated with erosions 16/36 (44%) vs. 
6/46 (13%) (p = 0.0014). 
 
Conclusions: Focal sialadenitis affected two-thirds and secondary SS one-thirds of the 
different rheumatic patients. The patients, irrespective of specific diagnosis, had various 
alterations in salivary flow and composition. The TMJ is commonly affected in patients with 
RA, and in patients with other forms of rheumatic diseases. There was a good association 
between radiographic findings and subjective symptoms, and between radiographic findings 
and restricted condylar movement. However, to obtain a more detailed anatomic picture, MRI 
is suitable for patients with acute unexplained pain or as part of preoperative work-up. 
Genetic factors seem to contribute to destructive lesions in the TMJ as well as composition of 
saliva in patients with various rheumatic diseases. 
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ABBREVIATIONS 
ANA= antinuclear antibody 
AS= ankylosing spondylitis 
CFU= colony forming unit 
C3= complement factor 3 
C4= complement factor 4 
CPI= Community Index of Periodontal (Treatment Needs) 
CRP= C-reactive protein  
DMARDS= disease modified anti-rheumatic drugs 
ENA= extractable nuclear antigen 
ESR= erythrocyte sedimentation rate 
Gd-DTPA= gadolium contrast medium 
HLA= human leucocyte antigen 
IgA= immunoglobulin A 
IgG= immunoglobulin G 
IgM= immunoglobulin M 
IQR= interquartile ranges 
JIA= juvenile idiopathic arthritis 
JLA= lateral panoramic tomography, special program of TM joint 
MCTD= mixed connective tissue disease 
MRI= magnetic resonance images  
RA= rheumatoid arthritis 
RF= rheumatoid factor 
RNP-AB= ribonuclear protein antibody 
SD= standard deviation 
Sm-AB= anti-Sm antibody 
SPA= spondyloarthropathy 
SS= Sjögren’s syndrome 
SSA-AB= SSA antibody 
SSB-AB= SSB antibody 
TMD= temporomandibular disorders 
TMJ= temporomandibular joint
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INTRODUCTION 
 
Sjögren’s Syndrome (SS) is a chronic inflammatory autoimmune disorder characterized by 
the triad of xerostomia, keratoconjunctivitis sicca, and another autoimmune disease (1). The 
disease was described first in 1888. Four years later, Mikulicz published a case report. In the 
1920´s, the disease was described in France and was the first to note the association between 
lacrimal gland abnormalities and athrophy of the mucous glands. In 1933, Henrik Sjögren, a 
Swedish ophthalmologist, published classical monograph, which resulted in 
keratoconjunctivitis sicca, xerostomia and rhinopharyngeal laryngitis (2). Several sets of 
diagnostic criteria for SS have been proposed, of which five are currently in general use. 
 
Secondary SS is known to occur with a variety of autoimmune diseases, such as RA (3), 
systemic lupus erythematosus (4), and primary biliary cirrhosis (5). The classification criteria 
for SS vary between study groups. According to Fox et al. (6), the verification should 
consider all three components of diagnostic relevance: focal sialadenitis in minor salivary 
gland biopsy, keratoconjunctivitis sicca and in the case of secondary SS, also an associated 
disease. The European classification criteria suggest that at least four out of six items 
(subjective oral and ocular symptoms, decreased tear secretion, decreased unstimulated 
salivary flow, focal sialadenitis by biopsy, and the presence of autoantibodies) correctly 
classify patients with primary SS (7). The classification of secondary SS accepts the presence 
of one of the two subjective symptoms with at least two objective items of glandular 
dysfunction (7). According to the new SS criterias, there have to be either focal sialadenitis or 
positive serology, while other criterias are the same (at least two objective items of glandular 
dysfunction) (8).  
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Oral infections have been associated with systemic diseases such as RA (9). Risk for 
periodontal disease has been substantially increased in patients with long-standing RA (10, 
11). However, data are sparse on periodontal condition in seronegative arthritides or MCTD 
and no studies have been conducted on periodontal disease in patients with SPA. Saliva 
secretion, which is the principal defensive factor in the oral cavity is affected by the rheumatic 
diseases with subsequent detrimental effects on teeth and mouth mucosa. Reduced salivary 
flow enhances oral microbial colonization, in particular yeasts which, in turn, are an 
infectious burden to the patient and may worsen the systemic condition (12,13). 
 
For a long time, it has been known that the temporomandibular joint (TMJ) can be involved in 
patients with rheumatic diseases (14). Examination of a 50-year old Egyptian male mummy, 
from the period of the Fifth Dynasty (2750-2625 B.C.), revealed typical changes of 
rheumatoid arthritis (RA)  in the joints of the hand and the temporomandibular joint (15). The 
prevalence of TMJ involvement in rheumatic diseases has been found to vary greatly, 
depending on the diagnostic criteria, the population studied and means of assessment of the 
TMJ. 
 
In previous studies, prevalences of clinically evident TMJ involvement have been reported to 
vary between 2%-98% in rheumatic patients, more often in RA patients. Use of conventional 
radiographic methods has allowed demonstration of frequent TMJ abnormalities in patients 
with RA, ankylosing spondylitis (AS), mixed connective tissue disease (MCTD), juvenile 
idiopathic arthritis (JIA) and psoriatic arthropathy (16-20). Typical findings are joint-space 
narrowing, and condylar erosion, flattening and sclerosis (16-19, 21). Inflammation of TMJ 
may frequently cause micrognathia in patients with juvenile idiopathic rheumatoid arthritis 
(20). 
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Genetic factors play a role in the development of rheumatic diseases. AS and 
spondyloarthropathy (SPA) are closely associated with human leucocyte antigen (HLA) B27 
(22, 23). The association of RA with HLA-DR4 (25-26), and in some of the populations with 
HLA-DR1 (27), is well established. However, results concerning the influence of HLA-DR4 
on disease severity have been conflicting. Many (28-31), but not all, studies (32-34) have 
described a more severe disease course in HLA-DR4-positive patients. The correlations 
between TMJ erosion and HLA antigens is not known yet. 
 
Magnetic resonance imaging (MRI) is being increasingly recognised as a useful method for 
early detection of destructive as well as inflammatory lesions. MRI shows mild arthritis and 
synovitis better than other radiographic methods (35, 36). MRI has also been applied in 
examination of the TMJ, where it can show abnormalities of the glenoid fossa, disc, articular 
cartilage, condylar shape and bone marrow (37). TMJ symptoms are frequent even in normal 
subjects, but more frequent in patients with inflammatory arthritis.  
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2 REVIEW OF THE LITERATURE 
 
2.1 Common rheumatic conditions 
 
The major groups of synovial joint disorders are inflammatory and non-inflammatory 
arthropathies (Table 1). 
 
2.1.1 Non-inflammatory arthropathies 
Non-inflammatory disorders refer to disorders in which joint dysfunction occurs in the 
absence of overt inflammation (Table 1). Osteoarthritis is the most common degenerative 
disease of synovial joints. It primarily affects the articular cartilage, probably due to its 
limited adaptive capacity compared with other connective tissues, and the subchondral bone. 
Primary osteoarthritis develops in the absence of any known underlying predisposing factor; 
in secondary osteoarthritis, an underlying local or systemic pathogenetic factor, e.g., trauma, 
surgery, recurrent dislocation, crystal deposition disorders, avascular necrosis, or post-
inflammation cartilage damage, can be identified (38). 
 
Osteoarthritis affects not only the articular cartilage but also the subchondral bone, the 
synovial lining cells, the synovial fluid and capsular ligaments. Osteoarthritis includes an 
inflammatory component caused by waste products and inflammatory mediators (i.e. 
osteoarthritis with synovitis). Throughout life, the articular cartilage and underlying bone 
display shifting equilibria between changes in form and function by tissue remodeling. The 
tissues adapt to applied stresses. When loading is beyond the limits of the system, 
compensatory responses may lead to new steady states. 
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Table 1. Classification of arthropathies 
Inflammatory arthropaties (arthritis) 
 
Non-inflammatory arthropathies 
Primary arthritis Osteoarthrosis (osteoarthritis) 
-Rheumatoid arthritis -primary 
-Juvenile idiopathic arthritis -secondary 
-Spondyloarthropathy  
-Ankylosing spondylitis Internal joint derangement 
-Psoriatic arthritis  Aseptic necrosis 
-Reiter´s syndrome  Synovial chondromatosis 
Arthritis following external insult  
Infective and infection-associated arthritis  
Traumatic arthritis  
Crystal-induced arthritis  
Systemic collagen vascular diseases  
-Systemic lupus erythematosus  
-Mixed connective tissue disease  
-Systemic slerosis (scleroderma)  
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Cartilage breakdown in osteoarthrosis affects the sliding properties of the joint surfaces. 
Deterioration of the synovial fluid in osteoarthrosis gives rise to friction and adhesive wear. 
Osteoarthrosis can be secondary as a result of other joint disorders, e.g., RA, avascular 
necrosis, and osteochondritis dissecans. 
 
In TMJ impairment the movement of the disc may cause disc degeneration. This may induce 
joint stiffness and repetitive stretching of the disc attachments. The attachments may 
gradually elongate to an extent that permits disc displacement. Although disc displacement in 
the TMJ is a real clinical entity, the position and form of a physiologically functioning disc 
have certain variations. Large percentage of patients have a different basis for their 
intracapsular symptoms than only disc displacement (38). 
 
2.1.2 Inflammatory diseases 
The common term for inflammatory joint disorders is arthritis (Table 1). 
 
2.2 Inflammatory rheumatic diseases 
 
2.2.1 Rheumatoid arthritis 
Rheumatoid arthritis (RA) is a systemic chronic disease, characterized by an acute 
inflammatory response, with symmetric polyarticular joint pain and swelling, morning 
stiffness, malaise, and fatigue. The inflammation may be reversible over months, and patients 
may experience spontaneous remission. However, most patients whose symptoms have 
persisted for longer than 90 days experience a progressive disease, in which the reversible 
inflammatory activity leads to irreversible joint damage. RA is found in approximately 0,5% 
to 1% of the population in many cultures (39). The prevalence of RA in the Finnish 
population is 0.8% (40). About 70% of the patients are female.  
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The disease can affect individuals at any age, including infants and aged individuals; 
however, the most common onset is in women aged 50 to 60 years (41). In Finland, the mean 
age is 59 year (41). 
 
While the disease course is highly variable in individual cases, many patients experience joint 
damage within the first 2 years of disease. Joint damage in RA ultimately has resulted in work 
disability in at least 50% of patients within 10 years, and the patients are prone to premature 
death.  
 
The clinical history of a patient with RA generally includes pain and symmetric swelling 
involving multiple joints. Any joint may be affected, but those most commonly involved are 
the metacarpophalangeal joints of the hand, proximal interphalangeal joints of the hand, 
metatarsophalangeal joints, wrists, knees, elbows, and, less commonly, shoulder, hip, and 
distal interphalangeal joints (42,43). 
 
A characteristic finding is morning stiffness, which may last for several hours after rising. 
Although RA is manifested primarily by joint involvement, it is a systemic inflammatory 
disease. Extra-articular involvement may be seen, including secondary SS with dry eyes and 
dry mouth, vasculitis, episcleritis, neuropathy, rheumatoid nodules and more rarely, Felty´s 
syndrome with splenomegaly and leukopenia.  
 
The etiology of RA remains unknown. Genetic factors in the presence of favorable 
environmental conditions are considered to play a role in the development of RA (44). 
Historically, RA was called chronic infectious arthritis, because the clinical and pathologic 
features of disease resemble those seen in chronic infectious diseases such as tuberculosis.  
 
 19 
One important host variable is the major histocompatibility locus. Human leukocyte antigen 
(HLA) –genes located within the major histocompatibility complex on chromosome 6p have 
been found to have a strong association with RA (13). Individuals carrying HLA-DR4 and 
HLA-DR1 alleles in particular have been shown to posses a higher risk of the disease. It has 
been suggested that the susceptibility alleles all share a single epitope that is responsible for 
the predisposition of  individuals to RA (42). It has also been suggested that the relationship 
of HLA and RA may be related more to the severity of the disease, rather than to the tendency 
to acquire RA (42). 
 
The diagnosis of RA may be made in the absence of any laboratory tests, and all laboratory 
tests may be normal in a proportion of patients (Table 2) (45). Nonetheless, four types of 
laboratory data may contribute to the diagnosis assessment of the severity of RA in an 
individual patient. Rheumatoid Factor (RF) is found approximately 70% to 90% of people 
with RA. People with a specific haplotype at the HLA-DR4 locus (*0401 or  *0101) have a 
five-fold higher likelihood of developing RA than an individual in the general population 
(43). In a population based stydy in Finland, occurense of HLA-DR4 was 54% in  patients 
with RA and in 30% with control patients (46).  HLA-DR4 is not a diagnostic test for RA for 
several reasons. Firstly, most people who have the *0401 or *0101 haplotype do not have RA. 
Secondly, only about 70% of people who have a diagnosis of RA have these haplotypes. 
Finally, although the *0401 and *0101 haplotypes are associated with a somewhat higher 
likelihood of radiographic damage and the presence of RF they are not associated with greater 
severity of disease other than  as a predictor some subtypes of RA. Therefore, a HLA typing 
test is not useful clinically in the diagnosis or management of patients with RA (43). 
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The treatment of RA based on combination of a non-steroidal anti-inflammatory drugs and 
disease modified anti-rheumatic drugs (DMARDS). Nowadays there are also biological 
medication available (i.e TNF-alfa-blockers).  
 
Table 2. Classification criteria of RA. 
At least four of following criteria. 
- Morning stiffness of joints (>1 hour) 
- Arthritis of three or more joint areas 
- Arthritis of hand joints 
- Symmetric arthritis 
- Rheumatoid nodules 
- Serum rheumatoid factor 
- Radiographic changes 
 
2.2.2 Connective tissue diseases  
Connective tissue diseases are a group of closely related conditions, with many overlapping 
clinical features. While uncommon, they cannot be considered rare. Systemic lupus 
erythematosus incidence in Finland is 8/1 milj. / year (47). Many of the features of connective 
tissue diseases involve the skin, joints, muscles or blood vessels. Serological examination 
reveals that connective tissue diseases are associated with a variety of  antinuclear antigens 
(ANA), and other related antibodies (i.e. antibodies to Sm, RNP antigens etc).  
Mixed connective tissue disease (MCTD) is a rare connective tissue disease, with typical 
features such as oedema or pale fingers, inflammatory arthritis and skin rashes. The dryness 
of mucosal surfaces may also be present.  
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Connective tissue diseases are associated with considerable morbidity even with increaced 
mortality. The treatment of MCTD based on anti-inflammatory- and DMARDS. 
 
2.2.3 Spondylarthritides 
The concept of spondyloarthropathy is based on mainly clinical findings. Several 
inflammatory arthritides have common features which include familial clustering, association 
with HLA-B27 (Table 3), predominant axial and peripheral asymmetrical joint involvement, 
enthesitis, extra-articular signs and negative RF. The incidence of the seronegative 
spondylarthritides (SPA) in Finland is 13/100 000 (47,48). 
 
 SPA (Table 3) form a group of disorders which share a number of characteristic overlapping 
clinical features (Table 4) and an association with HLA-B27. The most typical and common 
spondylarthritides is ankylosing spondylitis (AS). One therefore needs to be aware of these 
conditions as features of sacroilitis or spondylitis may occur later in, for example, patients 
with reactive arthritis or psoriatic arthritis. 
 
Table 3. Spondyloarthritis: grouped together with following clinical characteristics: 
1. Peripheral arthritis – lower limb, asymmetrical 
2. Radiological sacro-iliitis 
3. Negative for rheumatoid factor 
4. Absence of nodules and other extra-articular features of rheumatoid arthritis 
5. Overlapping extra-articular features characteristic of the group 
6. Significant familial aggregation 
7. Association with HLA-B27 
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Table 4. Spondyloarthritis 
- Ankylosing spondylitis  
- Reactive arthritis (Reiter´s syndrome) 
- A) sexually acquired reactive arthritis  
- B) post dysenteric 
- Arthropathy of inflammatory bowel disease 
- Psoriatic arthritis 
- ´Forme fruste´ and  ´undifferentiated´presentations 
- Certain forms of juvenile idiopathic arthritis 
 
Infection is the triggering factor in reactive arthritis. Infection can cause also other rheumatic 
conditions (Table 5). 
 
Table 5. Differential diagnosis of Reactive Arthritis 
- Disseminated gonogoccal infection 
- Rheumatic fever 
- Still´s disease 
- Psoriatic arthritis 
- Inflammatory bowel disease-associated inflammatory joint disease 
- Rheumatoid arthritis 
- Lyme arthritis 
 
Acute reactive arthritis is by no means always a benign self-limiting condition; there is 
progression to a chronic SPA in approximately 15-30% of cases (48). Recurrent attacks are 
more common in patients with chlamydia-triggered RA.  
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Enthesitis – inflammation at the insertion of tendon or ligament into bone – is a frequent 
feature in many forms of SPA and may involve synovial joints, cartilaginous joints and 
syndesomes as well as extra-articular entheses. In psoriatic arthritis, fatsuppressed T2-
weighted MRI show peri-entheseal inflammation and bone marrow oedema at entheseal 
insertions (49). These findings have led to the hypothesis that synovitis in psoriatic arthritis 
(and perhaps SPA in general) is secondary to entheseal inflammation, in contrast to the 
primary synovitis of RA (49). 
 
 Enthesitis in the SPA most frequently involves the lower limbs, perhaps related to the greater 
bulk or physical stress on entheses at these sites. Eye inflammation, especially uveitis, is a 
prominent extra-articular feature in SPA (Table 6). 
 
Table 6. Classification criteria for SPA (43) 
Inflammatory  
spinal pain 
  
  
AND one or more of the following: 
- Alternate buttock pain 
- Sacroilitis 
- Enthesopathy 
- Positive family history 
- Psoriasis 
- Inflammatory bowel disease 
Urethritis, cervicitis or acute diarrhoea within 1 month 
 
Synovitis: 
Asymmetrical or 
predominantly in lower 
limbs 
OR 
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Many patients with SPA and mild disease respond well to treatment with non-steroidal anti-
inflammatory drugs and physical therapy including physiotherapy, regular exercises and 
hydrotherapy. Persistent oligoarthritis is often improved by intra-articular steroids. SPA 
patients with severe peripheral joint disease commonly require treatment with a combination 
of a non-steroidal anti-inflammatory drugs and DMARDS. Biologically active agents, such as 
Infliximabe TNF alfa-blockers are increasingly used in patients with SPA (50). The 
DMARDS are used in the treatment of SPA largely overlap with those used in RA. 
 
2.2.4 Ankylosing spondylitis 
Ankylosing spondylitis (AS) is a chronic inflammatory disorder affecting predominantly, the 
axial skeleton although peripheral joint involvement may also be a significant feature. The 
disease affects synovial and cartilaginous articulations, and the sites of tendon and ligament 
attachment to bone (enthesopathy). The current diagnostic criteria included axial symptoms, 
limitation spinal movement, and radiological evidence of sacroiliitis (51). In the primary care 
setting it is a clinical diagnosis supported by radiological evidence of sacro-iliitis. The 
Prevalence of AS in Finland is 0.15% (52). 
 
The association with HLA B27 is greatest with AS (over 95%) (53) and weaker with psoriatic 
and enteropathic arthritis (Table 7). The typical presentation of AS is a young adult with 
insidious onset of back-pain and stiffness. Diagnosis of AS, which is frequently delayed for 
several years after presentation of symptoms, usually involves the finding of inflammatory 
back pain and limitation of spinal movement in multiple planes together with radiological 
evidence of sacroilitis. A misdiagnosis of mechanical pain with symptoms present for a few 
years is not unusual. In chronic progressive disease there is loss of lumbar lordosis with 
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increased thoracic and cervical kyphosis which becomes fixed as a result of fibriosis and bony 
ankylosis at which stage pain is generally less prominent. 
 
 
 
 
 
Table 7. HLA-B27-associated spondyloarthritides 
Disease HLA-B27 frequency % 
Ankylosing spondylitis 96% 
Undifferentiated spondyloarthropathy 70% 
Reactive arthritis 30-70% 
Colitis-associated spondyloarthritis 33-75% 
Psoriatic arthritis 40-50% 
Juvenile enthesitis-related arthritis 70% 
Iritis 50% 
Cardiac conduction defects with aortic 
incompetence 
Up to 88% 
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2.3 Sjögren’s Syndrome 
 
Dryness of the eyes or mouth are common subjective symptoms in general population. The 
menopause, diabetes mellitus and drugs such as anti-depressants are all associated with such 
symptoms.  
 
Sjögren’s Syndrome (SS) is characterized by an immune-mediated inflammatory process of 
the exocrine glands (1). It is generally divided into primary and secondary forms (53) based 
on whether or not another rheumatic disorder is present, such as RA or any of the other 
connective tissue diseases. Originally, sicca syndrome was defined as a trial of RA or another 
autoimmune disease, xerostomia and dry eyes (Table 8). The prevalence of primary SS has 
been estimated to range from <0.1% up to 0.4% in among Caucasian women in general 
practices (54). It has been described in 13.3% of patients in ambulatory patients attending a 
tertiary care centre (54). Signs of focal sialadenitis in labial submandibular and lacrimal 
glands were identified in 18.6% of 102 medicolegal post-mortem subjects in Finland (55). 
 In Northern lands there has been reported keratoconjuntivitis sicca syndrome in 14.9% and 
primary SS in 2.7% of patients (56).    
 
In most patients, the presenting complaint is dryness, typically of the eyes (xerophthalmia) or 
mouth (xerostomia). Tenderness or swelling of the parotid glands may also be seen. 
 Evaluation of patients with suspected SS may include biopsy of the minor salivary glands of 
the lip, imaging of the enlarged salivary glands etc. by scintigraphy or MRI, investigation of 
damaged ductal structures by sialography, functional tests of ocular or oral glands, and testing 
for autoantibodies. SS must be differentiated from other disorders that affect the salivary 
glands. Minor salivary gland biopsy is the only reliable method to diagnose the disease with 
certainty. 
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 Typical pathology consists of local aggreates of lymphocytes, plasma cells, and macrophages 
adjacent to and replacing the normal acini. Larger foci often exhibit formation of germinal 
centers. 
 
SS is more prevalent in women (female to male ratio 9:1). Although it usually appears in the 
fourth and fifth decades of life, it has also been described in children. In paediatric 
presentations, the youngest reported patient has been 3 years old. (57). Familiar aggregation 
in SS is common as up to 12% of patients have a similary affected relative (58).  
 
The aetiology of SS is still poorly understood. It appears that the autoreactivity observed 
(autoantibodies, lymphocytic infitrates of the exocrine glands) is probably due to the 
triggering of autoreactive clones by environmental factor(s) in genetically predisposed 
individuals.  
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Table 8. Adapted summary of the Greek, the European classification and the European 
criteria proposed by the American-European Consensus group criteria for secondary 
Sjögren’s syndrome. 
 
Criteria Skopouli et 
al 1986 
Vitali et al 1993 Vitali et al 1996 Vitali et al 2002 
Ocular component: 
1. Subjective 
 
 
2. Objective 
 
Xeropthal-
mia 
 
And  
Sch< 5mm/ 
5min or 
RB + 
 
Xeropthalmia 
(specif. Quest.) 
 
Sch I< 5mm/5min 
or 
RB: van 
Bijsterveld score 
>4 
 
Xeropthalmia or 
Xerostomia 
And 
Sch I< 5mm/5min 
or 
RB: van 
 Bijsterveld score 
>4 
 
Xeropthalmia or 
Xerostomia 
And 
Sch I< 5mm/5min 
or 
RB: van 
Bijsterveld score 
>4 
Oral component: 
1. Subjective 
 
 
2. Objective 
-saliva 
 
 
 
-biopsy 
 
Xerostomia 
 
And 
Parotid 
flow< 1 cc/ 
5min or 
RSGS  
 
And 
LSG> 2+ 
 
Xerostomia/ 
RSGS 
(specif. Quest.) 
Unstimulated SRF 
< 1.5ml/15min 
or 
Scintigraphy + or 
Sialography + 
 
LSG> 1 focus 
 
Xerostomia or 
Xeropthalmia 
And 
Unstimulated SRF 
< 1.5ml/15min 
or 
Scintigraphy + or 
Sialography + 
 or 
LSG> 1 focus 
 
Xerostomia or 
Xeropthalmia 
And 
Unstimulated SRF 
< 1.5ml/15min 
or 
Scintigraphy + or 
Sialography + 
or 
LSG> 1 focus 
Laboratory - RF+ or 
ANA+ or 
SSA/SSB-ab + 
 RF+ or 
ANA+ or 
SSA/SSB-ab + 
Exclusions - Lymphoma, 
GVHD, AIDS, 
Sarcoidosis 
 Lymphoma, 
GVHD, AIDS, 
Sarcoidosis, 
PHNRT, Hepatitis 
C infection, use of 
anticholinergic 
drugs 
Diagnosis of SSS Definite: > 
2/3 and 
LSG> 2+ 
Possible: 
>1/3 and 
LSG> 0 
> 4/6 criteria, no 
exclusions 
One or two subj. 
symptoms and at 
least two obj. 
items of glandular 
dysfunction 
Posit. serology or 
focal sialad. And 
one or two subj. 
symptoms and at 
least two obj. items 
of glandular 
dysfunction 
 
Sch= Shirmer test, RB= Rose-Bengal test, BUT= break-up time, RSGS= recurrent salivary gland swelling, SRF= 
salivary flow rate, LSG= labial salivary gland biopsy, KCS= keratoconjunctivitis sicca, 
 SSS= secundary Sjögren’s syndrome, RF=rheumatoid factor, ANA= antinuclear antibodies, GVHD= graft-
versus-host disease, AIDS= acquired autoimmune deficiency syndrome, PHNRT=Past head and neck radiation 
treatment. 
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The most typical clinical features of SS are symptoms of dryness in various glandular tissues: 
eyes, mouth, nose, posterior pharynx, larynx, respiratory epithelium, skin and vagina (59). 
 
Decreased tear secretion causes a sandy sensation in the eyes, burning, redness, 
photosensitivity, eye fatique, itching and disturbance of vision (60). Eye involvement in SS is 
diagnosed on the basis of decrease or qualitative  abnormalities in tear secretion, and lesions 
on the surface of the eye (52). The Schirmer´s tear test is used to assess tear secretion by the 
lacrimal glands. Keratoconjunctivitis  sicca, the sequela of decreased tear secretion, is 
diagnosed using an aniline dye (Rose Bengal) that stains the damaged epithelium of both the 
cornea and conjunctiva.  
 
The diagnosis of salivary gland involvement is based on the detection of functional 
impairment or anatomical changes resulting from an autoimmune inflammatory proccess in 
which the salivary glands are the main target. Decreased salivary flow may cause difficulty in 
chewing, swallowing and phonation, abnormalities of taste and smelling, fissures on the 
tonque, buccal membranes and lips, worsening of dental caries etc (1). Candida albicans is 
also detected more often in patients with SS than in healthy controls (61). Diminished salivary 
flow may also predispose SS patients to ascending sialadenitis (62). Parotid gland 
enlargement, often recurrent and symmetric, occurs in about half of secondary SS patients 
(63). The inflammatory infiltrates in the glands may be so large and numerals that swelling of 
the parotid glands or, more rarely, of the submandibular or sublingual glands may occur 
repeatedly during the course of the disease. 
 
A reduction in saliva production can be documented simply by collecting, in calibrated tube, 
the saliva produced by the patient in a certain amount of time. This test can be performed 
without or with stimulation (gustatory or masticatory), although conflicting results have been 
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obtained and it is not yet clear which is preferable. The current diagnostic criteria of  SS (8) 
include unstimulated secretion of saliva as one of the variables for the diagnosis. 
 
Sialometry allows a rough assessment of the functional status of the glands, although it is far 
from specific for SS. Salivary scintigraphy is an alternative method of assessing the functional 
status of the major salivary glands. The rate of tracer uptake in the glands and the rate of 
tracer secretion into the mouth are considered good indicators of the functional and 
anatomical integrity of the major salivary glands. The obvious disadvantage of this method is 
its high cost. Parotid sialography has frequently been used in the diagnosis of SS, sialectases 
being the most typical finding. MR imaging and MR sialography are noninvasive methods 
that provide definitive information of morphologic changes in parotid glands and can be used 
as diagnostic indicators of SS. MR sialography is more sensitive, but conventional MRI gives 
complementary information on the progressive pathologic changes  of glandular parenchyma 
(64). Minor salivary gland biopsy is the most widely used method of assessing oral 
involvement in SS. 
 
Autoantibodies are commonly detected in patients with SS, in particular RF, antinuclear 
antibodies, and antibodies to extractable nuclear antigens, termed Ro (SSA) and La (SSB). 
These autoantibodies are not specific for SS and may be found in other autoimmune diseases, 
especially in SLE. 
 
The treatments of SS is largely symptomatic with the goal of keeping the conjunctiva and 
mucosal surfaces moist. Artificial tears should be used regularly. Soft contact lenses may help 
to protect the cornea, especially in the presence of filimentary keratitis. 
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 Cigarette smoking and drugs with anticholinergic side effects should be avoided whenever 
possible. Treatment of xerostomia is difficult. Most patients learn on their own the importance 
of taking small sips of water frequently and carrying bottles of water with them at all times. 
Stimulation of salivary flow by chewing sugar-free gum or using lozenges is often helpful. 
Periodontal disease and tooth decay are serious problems in patients with xerostomia; thus, 
patients should be reminded of the importance of brushing their teeth after meals. Topical 
treatment of the teeth with stannous fluoride enhances dental mineralization and retards 
damage. Corticosteroids and immunosuppressive drugs such as oral or intravenous 
cyclophosphamide are used for patients with severe, progressive extraglandular disease. SS 
patients are at increased risk for the development of lymphoma.   
 
2.3.1 Minor salivary gland biopsy 
Minor salivary gland biopsy is the most widely used method of assessing oral involvement in 
SS. A sufficient amount of glandular tissue should be taken from the lower lip after a local 
incision midway between the midline and the corner of mouth. Harvestin of minor salivary 
glands can be done using single or more preferrably by small multiple incision. Focal 
sialoadenitis is a characteristic histopathological feature of SS. Daniels and Whitcher (65) 
reported a correlation between reduction of parotid salivary flow rate and inflammatory-focus 
score in lip biopsy specimens from patients with primary SS. 
 
There is as yet no consensus on the threshold focus score to be used for diagnosis. Some 
authors suggest a focus score >1 per 4 mm2 (66), while others accept a focus score of 1 as 
virtually diagnostic of SS (67). Although the presence of focal sialoadenitis is considered the 
most specific diagnostic test for SS, a similar histopathological picture has been demonstrated 
in conditions other than SS, e.g., primary biliary cirrhosis, bone marrow transplants, 
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 HIV infections, and myastenia gravis. An inflammatory focus is defined as an aggregate 
containing 50 or more mononuclear cells. The focus score os the number of such aggregates 
in a 4 mm2 area. 
  
Only two studies on repeat labial salivary gland biopsies in secondary SS patients have been 
carried out (68,69). The lesions were mainly progressive with time. They observed for their 
part morphological progression of sialadenitis in 14 out of 21 patients (67%) with primary SS, 
and in 14 out of 18 (78%) with secondary SS after a mean follow-up time of three years. 
 
2.4. Saliva and oral microbial flora 
2.4.1 Salivary flow 
The formation of saliva consists of formation of secretory fluid, made up of water and 
electrolytes and secretion of preformed proteins and enzymes, mainly originating from acinar 
cells. Salivary composition mainly depends on the source of the saliva and type of 
stimulation. Many causes can affect decreased salivary secretion (Table 9). The main organic 
components in saliva are proteins and glycoproteins, which are different in different 
secretions. Parotid saliva contains large amounts of glycoproteins, such as amylase, salivary 
peroxidase and IgA. More glycosylated glycoproteins, mucins, are typical of submandibular 
and sublingual secretions, making them viscous.  
 
Bacterial plaque is the major etiological factor of dental caries and periodontal disease. Saliva 
contains many substances, both innate and acquired, which can protect the oral tissues against 
bacteria (70). 
 
Many studies have been published about salivary flow in RA patients (13), but only a few 
reports have been published on sialochemistry in patients with AS and SPA, diseases that may 
also be associated with focal sialadenitis and SS (71).  
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Table 9. Main causes of decreased salivary production. 
ACUTE AND TRANSIENT CHRONIC AND USUALLY STABLE 
Short-term drug use (x) Chronically adminstered drugs (x) 
Viral and bacterial infections 
 (mumps, cytomegalovirus, coxsackle A) 
Sjögren´s syndrome 
Dehydration Granulomatous diseases 
(sacroidosis,tuberculosis, leprosy) 
Psychogenic (depression, anxiety, panic attacks) Amyloidosis 
 Human immunodeficiency virus infection 
 Graft-versus-host disease 
 Cystic fibrosis 
 Diabetes mellitus, hyperlipoproteinaemia 
 Ageing 
 Hepatitis C 
 Radiotherapy of the neck and head 
 
(x) antihistamines, antidepressants, anticholinergics, neuroleptics, anti-parkinsonians,  
anti-hypertensive agents (especially clonidine). 
 
2.4.2 Salivary biochemistry 
Amylase is the most important digestive enzyme in saliva, and a major component of parotid 
saliva. Amylase concentration is a marker of protein synthesis in the acinar cell (72). Van der 
Reijden et al. (73) have reported that concentrations of salivary amylase in cases of secondary 
SS were similar to those in controls.  
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Secretory IgA is the main immunoglobulin isotype of saliva (74). The main function of 
secretory IgA is to inhibit microbial colonization by aggregating bacteria and preventing their 
adhesion (74). Elkon et al.(75) found that salivary IgA concentrations were higher in RA 
patients with dry eyes than in control subjects and that even RA patients without dry eyes 
exhibited high concentrations of salivary IgG. Mandel and Baurmash (76) found higher 
salivary IgA concentrations in patients with primary SS than in control subjects. High levels 
of IgA, IgG, and IgM have also been reported in whole saliva from patients with secondary 
SS (75, 77-79). In a normal population, concentration of IgA in saliva is inversely related to 
salivary flow rate. Stimulating flow results in dilution of IgA both in the parotid and whole 
saliva (78). Ben-Aryeh et al. (79) have suggested a positive correlation between focus score 
and salivary IgA concentration. The increases in salivary IgA and IgG concentrations detected 
in primary and secondary cases of SS could result from massive infiltration of salivary glands 
by B cells, or leakage from serum into the damaged glands (80). High numbers of IgG-
producing plasma cells have been observed in lymphocytic infiltrates of minor salivary gland 
biopsy specimens in patients with secondary SS (81). 
  
High serum IgA concentrations are characteristic in active AS (82). It has been suggested that 
it results from stimulation of the gut immune system by Gram-negative bacteria in the gut 
(83). Use of sulfasalazine by patients with active AS has been shown to restore the levels to 
normal of IgA in serum (81) and of secretory IgA in the gut (84).  
 
The high levels of salivary albumin may indicate decreased mucosal integrity in the oral 
cavity, like what is seen in the gut of AS patients (77). High salivary albumin concentrations 
have previously been reported in RA, SS and control subjects (75) and, for example, in 
patients treated for lymphoma (78). 
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Increased concentrations of salivary albumin, cystatin C and S, IgA and total protein, but not 
amylase, have been reported in relation to both primary SS and in RA patients with secondary 
SS (65). Information on the composition of saliva in patients with MCTD, an autoimmune 
disease in which SS is also often seen (19) is sparse, however. 
 
2.4.3 Oral microbial flora 
The normal oropharyngeal flora is made up of more than 400 bacterial species. Thirty per cent 
of the bacteria are aerobic, 70% anaerobic (79). Concentrations of bacteria in saliva vary 
between 10(8) and 10(9) CFU/ml. In the gingival sulcus and pockets, especially in 
periodontitis, anaerobic Gram-negative rods are present (80). In healthy individuals, Gram-
negative bacteria (2-18%) are rarely isolated from the oropharynx (81). 
 
2.5. Oral health  
Systemic health is often closely linked to the state of the oral cavity: many systemic diseases 
and conditions have oral manifestations. Population-based studies now suggest the 
periodontal diseases may be linked with systemic diseases and conditions including 
cardiovascular diseases, diabetes, respitatory diseases, adverse pregnancy outcomes, and 
osteoporosis (82,84). 
 
There is good evidence to suggest that individuals with moderate to severe periodontal 
disease are at higher risk of suffering from RA and vice versa (10, 11).  
 
SS is known to occur in association with various rheumatic diseases (19, 3, 85). In Primary 
SS incidences of caries and changes in the oral mucosa are relatively high (78, 86, 73, 87). 
Oral infections have been associated with systemic diseases such as RA (9). Risk for 
periodontal disease has been substantially increased in patients with long-standing RA (10, 
11). However, data are sparse on periodontal condition in seronegative arthritides or MCTD 
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and no studies have been conducted on periodontal disease in patients with SPA. Saliva 
secretion, which is the principal defensive factor in the oral cavity is affected by the rheumatic 
diseases with subsequent detrimental effects on teeth and mouth mucosa. Reduced salivary 
flow enhances oral microbial colonization, in particular yeasts which, in turn, are an 
infectious burden to the patient and may worsen the systemic condition (13).  
Salivary secretion depends on the general state of hydration but is mostly affected by systemic 
diseases and drugs (13, 19).  
 
A close correlation between minor salivary gland inflammation and whole salivary secretion 
has  been observed (88). Similar to the situation in other organs, the salivary glands can 
compensate functionally for modest loss of parenchyma. In the early stages of disease, 
stimulated flow rates may therefore be normal or only slightly reduced. In later stages, 
however, there is a much greater loss of tissue and stimulated flow rates may be significantly 
reduced.  
 
2.6. Temporomandibular joint 
2.6.1 Anatomy 
The temporomandibular joint (TMJ) obeys the same biologic laws as do other synovial joints 
in the body, except that this joint has fibrocartilage on articular surfaces, while most other 
joints have hyaline cartilage (38). The thin, loose fibrous capsule surrounds the articular 
surface of the condyle and blends with the periosteum of the mandibular neck. On the 
temporal bone the articular capsule completely surrounds the articular surfaces of the 
eminence and fossa. Attachments of the capsule adhere firmly to bone. Anteriorly, the capsule 
is attached in front of the crest of the articular eminence; laterally, it adheres to the edge of the 
eminence and fossa; and posteriorly, it extends medially along the anterior lip of the 
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squamotympanic and petrotympanic fissures. The medial attachment runs along the 
sphenosquamosal suture. The articular capsule is strongly reinforced laterally by the 
temporomandibular (lateral) ligament, composed of a superficial fan-shaped layer of 
obliquely oriented connective tissue fibers and a deeper, narrow band of fibers that run more 
horizontally. The ligament attaches broadly to the outer surface of the root of the zygomatic 
arch and converges downward and backward to attach to the back of the condyle below and 
behind its lateral pole. 
 
The articular disc is a firm but flexible structure with a biconcave shape. The disc is divided 
into three regions: posterior band, intermediate zone, and anterior band. The central 
intermediate zone is considerably thinner than the posterior and anterior bands. The upper 
surface of the disc adapts to the contours of the fossa and eminence of the temporal bone, and 
the lower surface of the disc adapts to the contour of the mandibular condyle. 
 
Posteriorly, the disc and the loosely organized posterior attachment tissues (bilaminar zone, 
retrodiscal tissue) are contiguous. The retrodiscal tissue is a soft, areolar connective tissue 
with large vascular spaces. The posterior attachment tissues are attached to the tympanic plate 
of the temporal bone posterosuperiorly and to the neck of the condyle posteroinferiorly. 
Anteriorly, the disc and the capsule and fascia of the superior head of the lateral pterygoid 
muscle are contiguous. The superior head of the lateral pterygoid muscle may have some 
fibers inserting directly into the disc anteromedially (Figure 1). 
 
The articular disc of the TMJ is a hypovascular intra-articular structure that separates the 
condylar head from the glenoid fossa. It is firmly attached to the condyle at its lateral pole 
while it is not directly attached to the temporal bone. The articular disc and its posterior 
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attachment tissues merge with the capsule around their periphery. The disc and its 
attachments divide the joint space into separate superior and inferior spaces. In the sagittal 
plane, the upper joint space is contiguous with the glenoid fossa and the articular eminence. 
The upper joint space always extends farther anteriorly than the lower joint space. The lower 
joint space is contiguous with the condyle and extends only slightly anterior to the condyle 
along the superior aspect of superior belly of the lateral pterygoid muscle. In frontal plane, the 
upper joint space overlaps the lower joint space. Therefore, entrance through the lateral 
capsule starts in the superior compartment (89).  
 
 
Figure 1. Temporomandibular joint (with permission modified after Okeson 2003 (89)) 
 
 
 
2.6.2 Imaging 
2.6.2.1 Panoramic tomography 
Plain radiography of TMJ, panoramic tomography and lateral panoramic tomography can be 
valuable for initial screening for osseus abnormalities, such as fractures and advanced 
degenerative joint disease. In addition, these methods can be applied in the examination of 
inflammatory changes of TMJ (90). The panoramic radiograph is suitable (91, 92) and is also 
1. Disc             6. Inferior joint cavity 
2. Condyle             7. Superior joint           
                 cavity 
3. Fibrocartilage        8. Superior belly of     
        lateral pterygoid 
4. Capsular ligament           muscle 
5. Retrodiscal tissue   9. Inferior belly of  
  lateral 
               pterygoid muscle 
 39 
justified by its small dose of radiation (65) and for providing sufficient information on TMJ 
pathology (91). 
 
2.6.2.2 Lateral panoramic tomography 
The joint lateral (JLA) program is designed for obtaining lateral views of the TMJ’s. Both 
TMJ’s are imaged on the same film. The image layer is nearly straight, vertically located, 
with a slight angulation ventrally toward the midline. The JLA program is used for 
examination of various disorders of the TMJ’s as well as the mastoid area. The TMJ’s can be 
imaged with the mouth closed or open (94). 
 
2.6.2.3. Magnetic resonance imaging 
The overall advantage of magnetic resonance imaging (MRI) as a diagnostic tool is its ability 
to visualize soft tissue as well as bony structures (95). MRI has been used in RA to 
characterice both bone damage and synovitis. Periarticular bone erosion as shown by 
conventional radiography is the most characteristic feature of RA. 
 
Conventional radiographs detect cortical bone decalcification, but MRI demonstrates marrow 
changes and, therefore, has a different pathological significance. Radiographic erosions are 
uncommon in early RA, and several studies have shown that MRI is superior for showing 
bone damage in disease of less than 12 months duration (96).  
 
Most patients with RA have MRI-detectable bone changes. In addition, studies of the wrist, 
finger and shoulder joints have confirmed the greater sensitivity of MRI for bone changes in 
more long-standing discease. The longitudinal use of MRI as a surrogate marker for disease 
activity has also been assessed. MRI may be more sensitive than clinical assessment for 
diagnosing early synovitis. This has important implications for the early diagnosis of RA and 
a preliminary study has shown that MRI criterion had high sensitivity and specificity for 
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subsequent clinical diagnosis of RA. The earliest MRI bone change in RA is bone oedema 
which is secondary to synovitis. Bone oedema seems to be the forerunner of frank bone 
erosion (97). 
 
 MRI and ultrasonography are superior to computer tomography in detecting small erosions. 
Ultrasonography, MRI and computer tomography detect large erosions quite similarly. Plain 
radiography misses small erosions (98). 
 
MRI without contrast has been widely used in diagnosing internal derangement of TMJ 
without relation to an arthritic disease, such as disc displacements (99-106). There seem to be 
a general acceptance of using the method by Drace and Enzmann (107) in defining the correct 
disc position in the TMJ verified by MRI. Although the disc is a rather small structure it is 
very easy to see on non-enhanced MRI. Also the disc morphology can easily be described on 
MRI (108). In addition, MRI has proven to be very effective in diagnosing bony changes in 
the TMJ (108-111) in patients with functional TMD. There is general agreement, that MRI is 
superior to conventional radiographic examination or tomographs (37, 112-113). The 
presence of synovitis in TMJ is best determined with MRI using Gadolinium contrast medium 
(Gd-DTPA).  
 
MRI in relation to diagnosing TMJ involvement in patients with an arthritic disease is only 
sparcely described. Larheim et al.1990 (37) compared MRI findings of the TMJ in patients 
with RA with tomographies of the same joints, and found that there was good agreement 
between the two imaging modalities regarding surface irregularities and that MR imaging 
even demonstrated more extensive bone abnormalities than did tomography in some of the 
TMJs. The potential of MR imaging for depicting bone and soft-tissue abnormalities 
associated with rheumatic TMJ involvement was clearly demonstrated. 
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Only one study describes contrast-enhanced MRI of the TMJ (114). Smith et al have 
performed MRI enhanced with Gd-DTPA of the TMJ in adults with RA and in patients 
without a rheumatic disease and a few asymptomatic adults (114, 115).  
They found, that the synovium in the TMJ in the non-rheumatic patients with signs of TMJ 
disorder and in the healthy adults did not enchance whereas the synovium in the patients with 
rheumatic disease enhanced clearly.  
 
When imaging of TMJ by MRI, there are sagittal and coronal projections. While coronal 
sections give more information about disc dislocation and thickening of joint capsule, the 
sagittal projections are more useful in showing the disc and its position in relation to condylar 
head (16).  
 
2.6.3 Pathology 
In the ”temporomandibular joint osteoarthrosis concept”, different conditions of the articular 
cartilage are described, i.e., from normal variation to initial degenerative changes, from initial 
degenerative changes to advanced changes, and finally to destroyed cartilage. 
 
Based on these assumptions, when classifying temporomandibular arthopathies, osteoarthritis 
with and without disc displacement should be distinguished. A twelve o´clock position of the 
posterior band of the disc is no longer a standard of normal, since asymptomatic normal 
subjects show disc malposition and deformity in a significant portion of the studied 
population (38). 
 
Synovitis refers to inflammation of the synovial membrane. It results in an escape of fluid into 
the joint cavity (effusion), and alterations in the composition of the synovial fluid. When 
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severe, necrosis and fibrin deposition on the synovial surfaces may cause adhesions, which 
reduce the joint space and eventually may lead to fibrous ankylosis. 
 
Capsulitis describes inflammation of the outer layer of the capsule. It is characterized by pain 
with capsular stretching. Clinically, capsulitis is indistinguishable from synovitis. Most 
commonly, capsulitis results from stretching the capsule beyond its physiological range, e.g., 
due to habits (e.g. brukxism) or local trauma. During the healing process, the capsule may 
adhere to adjacent tissue (adhesive capsulitis) or heal in a shortened state (capsular fibrosis). 
 
2.6.3.1 Temporomandibular disorders 
Temporomandibular disorders (TMD) are defined as a collective term embraging number a 
clinical problem that involve the masticatory muscles, the TMJ and associated structures (89). 
TMD has several possible causes: 
• Muscle tension. Muscle tightness in the TMJ usually results from overuse of muscles. 
This overuse in turn is often associated with psychological stress and clenching or 
grinding of the teeth (bruxism).  
• Injury. A direct blow to the jaw or the side of the head can result in bone fracture, soft 
tissue bruising, or a dislocation of the temporomandibular joint itself.  
• Arthritis. Both osteoarthritis and rheumatoid arthritis can cause TMD.  
• Internal derangement. Internal derangement is a condition in which the cartilage disk 
lies in front of its proper position. In most cases of internal derangement, the disc 
moves in and out of its correct location, making a clicking or popping noise as it 
moves. In a few cases, the disc is permanently out of position, and the patient's range 
of motion in the jaw is limited.  
• Hypermobility. Hypermobility is a condition in which the ligaments that hold the jaw 
in place are too loose and the jaw tends to slip out of its socket.  
• Birth abnormalities. These are the least frequent cause of TMD but do occur in a 
minority of patients. In some cases, the top of the jawbone is too small; in others, the 
top of the jawbone outgrows the lower part. 
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The symptoms of TMD depend in part on its cause. The most common symptoms are facial 
pain in front of the ears; headaches; sore jaw muscles; a clicking sound when chewing; a 
grating sensation when opening and closing the mouth; and temporary locking of the jaw. 
Some patients also report a sensation of buzzing or ringing in the ears. 
Usually, the temporomandibular joint itself is not painful. Most cases of TMD are seen in 
women between 20-50 years of age. The symptoms are usually aggravated by function, wide 
opening for prolonged periods of time such as during dental treatment, and with the chewing 
of hard and chewy food (18, 89). Pain is frequent in the preauricular area and is often 
experienced as ear pain (90). Compression of the retrodiscal tissue (bilaminar zone) has been 
proposed and is one possibility as the source of the pain. Others are the inflammatory changes 
secondary to internal derangement, stretching of the joint capsule, and synovitis. Another 
important source of pain is the masticatory muscles. With an abnormally functioning joint, the 
patient frequently develops tender muscles that can be experienced as facial pain (116). 
Although it frequently is difficult to distinguish muscle and joint pain on physical 
examination (90), the tenderness in masticatory muscles in a patient with rheumatic disease is 
a good indicator of TMJ inflammation. Also, it might refer to the presence of permanent TMJ 
destruction. Bruxism and direct facial trauma all have been proposed as possible aetiologies 
of TMD. 
 
2.6.3.2 Rheumatoid arthritis  and temporomandibular joint 
The reported frequency of clinical TMJ involvement in patients with RA has varied from 2% 
to 98% (86), and most studies indicate that more than 50% of patients with RA exhibit 
clinical involvement of the TMJ (16, 117-120), but even then TMJ symptoms are usually 
minor (119-121). Wenneberg et al. (17) studied 61 patients with RA, 61 with psoriatic 
arthritis, 61 with AS, and 77 non-matched control subjects. 
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 TMJ changes were observed radiologically in 66% of the RA patients, 38% of the psoriatic-
arthritis patients and 30% of the AS patients but in only 12% of the control subjects. The 
changes seen radiologically, especially cortical erosions and the presence of subcortical cysts, 
were more severe in the RA patients than in the AS or psoriatic arthritis patients. Subjective 
TMJ symptoms and clinical findings relating to the TMJ were more common in the RA and 
AS patients than in the control subjects. Erosions and cysts of the mandibular condyle are 
typical radiological findings in patients with RA (119). In early RA, synovial proliferation 
and joint effusion can be observed in MRI of the TMJ (35, 120, 121). 
 
2.6.3.3 Mixed connective tissue disease and temporomandibular joint 
MCTD is a heterogeneous disease, in which the clinical features of the patients vary 
considerable between the patients and also with time. Some of the patients end up with an 
erosive peripheral arthritis (122). There is only one study report of MCTD and radiographic 
TMJ changes (19) TMJ erosion was found in 7 out of 10 MCTD patients. Erosion of the 
condyle resembling changes seen in RA was detected in 4 of 10 MCTD patients (19). In one 
patient limited function of TMJ was observed (19).  
 
2.6.3.4 Ankylosing spondylitis and temporomandibular joint  
The frequency of TMJ involvement in patients with AS has varied from 4% to 35% 
depending on the diagnostic criteria, the population studied, and the tools used to assess TMJ 
involvement (123, 129). Crum and Loiselle (1971) reported that 16% of patients with AS had 
complaints of pain and tenderness in the region of the TMJ’s, with limited jaw opening. 
Davidson et al reported that 10% of patients with AS had restricted jaw opening (125). 
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 Ramos-Remus and Major et al  (126) studied 65 AS patients and 22 control subjects and 
found that TMJ involvement is frequent in AS patients and is associated with variables that 
suggest more severe disease. Könönen et al (123) reported that TMJ involvement was found 
in 32% of the patients with AS. 
 
2.6.3.5 Spondyloarhropathy and temporomandibular joint  
There are only a few studies relating to SPA patients other than those with psoriatic 
arthropathy. In a recent study, it was found that patients with Reiter’s disease frequently 
exhibited TMJ symptoms and that 33% had radiographic evidence of erosions (126). 
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3. AIMS OF THE STUDY 
 
The present series of studies were undertaken to investigate the oral health and TMJ in 
various rheumatic diseases (RA, MCTD, AS and SPA). 
 The specific aims were: 
 
1.  To study the prevalence of focal sialadenitis in patients with various rheumatic diseases. 
To correlate focal sialadenitis with possible xerostomia or decreased tear secretion in 
these patients. 
 
2. To investigate oral health status, prevalence of dental pathogens and yeasts, as well as 
salivary flow rates and composition in patients with various rheumatic diseases. 
 
3. To investigate the associations between clinical and radiographic findingsof the TMJ in 
patients with various rheumatic diseases. 
 
4. To investigate whether certain HLA alleles are associated with TMJ erosions, salivary 
composition and signs of focal sialadenitis in patients with a wide spectrum of rheumatic 
diseases. 
 
5. To investigate MRI findings of the TMJ in various rheumatic diseases and compare them 
to clinical and radiographic tomographic findings.  
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4 MATERIALS AND METHODS 
 
4.1 Study design 
The whole study was carried out from September 1996 to August 1998. All consecutive 
patients with MCTD, AS, and SPA treated at the Outpatient Department of Rheumatology of 
the Meilahti Hospital, Helsinki University Central Hospital, were asked to participate in the 
study. During the same period, patients belonging in to a prospective cohort of early RA 
started in 1986-1989 were asked to participate. Participation was requested irrespective of the 
presence of oral or ocular symptoms. All patients initially gave their informed consent, but 
three patients (one with MCTD, one with AS, and one with SPA) later withdrew it (Study I, 
N=85). 
 
The controls were randomly selected volunteers, patients and staff of the Institute of Dentistry 
of the University of Helsinki. Each control was matched for sex and age (+2) with a patient. 
No control had any history of diabetes, rheumatic disease or any other disease affecting the 
masticatory system. 
 
The HLA-antigen frequencies for the Finnish population were derived from 100 healthy 
Finnish blood donors, which were randomly picked up from 3000 blood donors. The controls 
were not clinically or radiologically examined. 
 
In study IV, one RA patient was excluded from the original study group, since determination 
of HLA alleles was not available. In study III, one RA, three MCTD, and one SPA patient 
were excluded, due to missing recent panoramic tomography (N=2) or answers on TMD 
questionnaire (N=3). In study II, one RA, four MCTD, one AS, and two SPA patients were 
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excluded, due to missing recent panoramic tomograms (N=2) or saliva samples (N=6). Sixty-
seven patients with rheumatic diseases participated in study V. Of the 85 patients originally 
studed, 67 (79%) had a complete set of MRI available. Seventeen patients did not undergo a 
complete MRI examination for a variety of reasons, including acute panic disorder (four), 
severe kyphotic spinal deformity (two), incomplete MRI examination (six), and refusal by the 
patient (five). 
 
4.2 Study population 
The study population consisted of 25 patients with RA, 19 with MCTD, 19 with AS, and 22 
with SPA (Study I) (Table 10). Of these patients, 77 participated in Study II (24 with RA, 15 
with MCTD, 18 with AS and 20 with SPA), 80 in study III (24 with RA, 16 with MCTD, 19 
with AS, and 21 with SPA), 84 in study IV (24 patients with RA, 19 with MCTD, 19 with AS, 
22 with SPA), and 67 in study V (16 patients with RA, 15 with MCTD, 17 with AS, 19 with 
SPA). In studies II and III, an age and sex matched controls were also evaluated. In study IV, 
100 healthy blood donors served as control subjects. 
 
All RA patients fulfilled the American Rheumatism Association 1987 classification criteria 
for RA (45), MCTD patients met the criteria for the diagnosis by Alarcon-Segovia (127), and 
AS patients fulfilled the modified New York criteria for definite ankylosing spondylitis (128). 
Other patients with seronegative oligoarthritis or spondylitis not fulfilling the diagnostic 
criteria for AS were grouped into SPA patients and fulfilled the European Spondylarthropathy 
Study Group criteria (129). No patient was suffering from psoriatic arthropathy. 
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 4.3 Questionnaire 
All patients filled out a questionnaire on eye and oral symptoms according to the European 
Community Study Group Diagnostic Criteria for SS (128) with the following modifications 
(Appendix). For the ocular symptoms, the question about persistent or recurrent tear gland 
involvement was omitted, and a question about drugs with potential to cause decreased salivary 
flow was added. The questionnaire includes also questions on ear and TMD (Appendix). 
 
Answers were checked during personal interviews (LMJH). At the time of the examination, the 
examiner was unaware of the clinical diagnosis of the subjects. In addition, questions concerning 
facial trauma, headache and chewing habits were also included.  
 
The severity of TMJ symptoms in the patients was assessed on the basis of responses to the 
question:”How would you describe your TMJ symptoms?” Responses were graded as 1 (no 
discomfort or very minimal discomfort), 2 (mild discomfort), 3 (moderate discomfort), 4 (severe 
discomfort) or 5 (very severe discomfort). During data analysis grades 3 to 5 were combined and 
described as “severe symptoms” (Appendix). 
 
 Use of medication over the whole disease period and the use of DMARDS, other drugs for chronic 
diseases, and antidepressants –for example, antihypertensive, sedative, anticholinergic- were 
recorded. All patients were allowed to continue with their routine medication. Because sulfasalazine 
can induce autoimmune effects (129), duration of use of this drug was separately classified (0 to less 
than three months, three to 11 months, 12 months or more).Use of sulfasalazine at the time of 
examination was also recorded. Patients were further divided into three groups with respect to the 
use of glucocorticosteroids (current users, ex- users, and non- users of glucocorticosteroids). 
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4.4 Clinical examination 
The patients and controls were examined in a normally equipped dental office using World Health 
Organization recommendations for clinical recording. Dental status, including signs of dental 
infection foci, caries lesions, periodontal status and oral mucosal diseases were recorded for each 
subject. “Periodontitis” was recorded if the CPI was of score 3 or more (130). To assess dryness of 
the eyes, Schirmer’s test was performed using standardised tear strips (Clement Clarke, Edinburgh, 
UK), placed for five minutes on the conjunction at the most lateral part of the inferior lid, without 
previous use of anaesthetic eye drops. The patients sat with eyes closed, but not shut tight.  
 
All patients were subjected to a routine stomatognathic examination (17,131) to detect signs or 
symptoms of TMD, and to allow the occlusion to be recorded. The examination included palpation 
of the masticatory muscles and the TMJ. Tenderness was recorded whenever palpation resulted in 
reflex or the patient reported subjective discomfort. TMJ sounds i.e. clicking and crepitation were 
recorded from each side separately. Maximum ranges of mouth opening movement and lateral 
movements of the mandible were measured to the nearest millimetre, using a ruler (21) and pain 
during these movements was recorded. Deviations of more than 2 mm during opening and closure 
were also recorded. The occlusion was examined and use of removable dentures and any loss of 
molar support were recorded. During examination of the occlusion unilateral contacts in the 
retruded contact position, laterotrusion-, mediotrusion- and protrusion interferences, 
in accordance with the method of Wenneberg and Kopp (17) were also recorded. 
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4.5 Laboratory examinations 
Venous blood samples were collected from the patients and serum concentrations of serum IgA, 
IgG, IgM concentrations were determined by means of immunoturbidometry. The standard 
laboratory tests included whole blood cell count and erythrocyte sedimentation rate (ESR). C-
reactive protein (CRP), creatinine and rheumatoid factor (RF) were determined. Serum C3 and C4 
concentrations, and antibodies to SSA, SSB, RNP and Sm, as well as antinuclear antibodies and 
antibodies to hepatitis C were determined. All analyses were carried out in the hospital laboratory 
using routine clinical chemical procedures. Due to ethical reasons, no blood samples were taken 
from the controls. 
 
4.6  Saliva 
The patients and controls provided resting and stimulated saliva samples according to routine 
procedure of our hospital (132). Values for resting flow rates of less than 0.1 ml/min and for 
stimulated flow rates of less than 0.7 ml/min were taken to indicate reduced flow rates. Values for 
pH and buffering capacity (regarded as normal if the final pH was 4.0 or more) were determined 
immediately after collection by means of the Dentobuff-Strip® method (Orion Diagnostica, Espoo, 
Finland). Salivary pH was measured using a pH indicator paper and the values were classified as 
normal if 6.5 or more. Rest of salivas was centrifuged and deep frozen (-70 oC) until further 
analyses.  
 
4.6.1 Salivary microbes 
Cotton swab samples from the tongue were taken to inoculate Oricult-N® dip-slides (Orion 
Diagnostica, Espoo, Finland) for the assessment of yeasts. Counts of mutans streptococci (SM) and 
lactobacilli (LB) were assessed by the Dentocult -SM Strip Mutans® and Dentocult-LB® dip-
slides, respectively (Orion Diagnostica, Espoo, Finland). Actinobacillus actinomycetemcomitans 
(A.a.), Porphyromonas gingivalis (P.g.), 
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 Bacteroides forsythus (i.e. Tannerella forsythensis) (B.f.) and Prevotella intermedia (P.i.) were 
analyzed from saliva samples using PCR methods according to Wahlfors et al. (133) and Meurman 
et al. (134). 
 
4.6.2 Salivary biochemical analyses  
Amylase was determined immediately after thawing the saliva samples, using an enzymatic 
colorimetric test (MPR 3 EPS method, Boehringer Mannheim GmbH, Mannheim, Germany), total 
protein by means of the colorimetric Lowry method and albumin according to Webster (132) using 
human serum albumin standards. Salivary IgA, IgG and IgM levels were determined by means of 
the enzyme immunoassay (135). Results were based on at least duplicate assays and standards and 
controls were used in all the analyses. 
 
4.7 HLA-alleles (tissue typing) 
HLA typing for A, B, C antigens was performed in all patients according to the standard 
microlymphocytotoxicity test and for DRB1* alleles at the low resolution level using the 
commercial PCR / reverse dot-blot hybridization kit (INNO-Lipa, Innogenetics, Belgium) covering 
all common alleles DRB1*01-DRB1*14 at the Finnish Red Cross Blood Transfusion Service, 
Helsinki, Finland. The control population for HLA was typed at the same laboratory. 
 
 
 
 
 
4.8 Minor salivary glands 
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Rheumatic patients underwent minor salivary gland biopsy. Minor salivary gland biopsies were 
performed according to the procedure suggested by Daniels (136). After local anaesthesia, a 1.5 cm 
incision was made parallel to the vermilion border in the lower lip, between the midline and the 
corner of the mouth.  
Between 5 and 10 lobes of labial glands were obtained by blunt dissection. After removal, the 
mucosa was reapposed by 2 to 3 interrupted sutures. 
 
Technique 
All glands were embedded in paraffine along the same plane, to provide midplane sections through 
all glands. Sections 5 µm thick were stained with haematoxylin and eosin and were evaluated under 
the microscope at 4 × magnification, using a graticule to measure the number of foci per mm2. The 
focus score was defined as the number of agglomerations of at least 50 mononuclear cells per 4 
mm2 of glandular tissue. The lymphoplasmacytic foci occurred adjacent to normal appearing acini. 
Focal sialadenitis was defined as focus score ≥1 (137) (Figure 2 and 3). If agglomerations of at least 
50 mononuclear cells were observed, but their amount was below one per 4 mm2 of glandular 
tissue, the focus score is expressed as <1. The histopathology and ranking procedures were 
performed blind by one investigator (JHH), who was not aware of the diagnosis or symptoms of the 
patients.  
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Figure 2.  Focal sialadenitis in small salivary gland biopsy in patient with MCTD 
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Figure 3. Focal sialadenitis in small salivary gland biopsy in patient with RA 
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4.9 Radiology 
TMJs were examined by means of the Scanora Soredex® X-ray equipment by using standard 
orthopanthomography, and the lateral view program. The radiographs were analysed independently 
by two observers (LMJH and DH) blinded to the clinical characteristics of the patients and controls. 
In borderline cases the more conservative option was chosen. 
 
Panoramic tomography of the jaws was taken and lateral panoramic images of both joints (94) were 
examined in patients. Lateral panoramic tomographs were taken only the rheumatic patients.  
Erosion in condyles in the radiographs was scored by using an arbitrary scale with five grades from 
0 (no erosion), 1 (only very slightly eroded), 2 (erosion in top of the condyle), 3 (half of condyle 
eroded) to 4 (condyles completely eroded) (Figure 4). During analysis scores from 0 to 2 were 
classed as normal or reflecting mild changes and scores from 3 to 4 as reflecting marked erosion. 
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Figure 4a-4d. Examples of TMJ erosions for the 4 grades. A, very slight erosion in condyle (1). 
 B, erosion of top of condyle (2). C, half of condyle eroded (3). D, condyle completely eroded (4). 
 
 
 
 59 
Analysis of the tomograms focused particularly on signs of dental infection foci. Radiolucent cystic 
lesions, dental furcation lesions, residual roots, retained teeth with enlarged follicles, pericoronitis, 
horizontal alveolar bone loss, deep vertical periodontal pockets, radiologically visible dental caries, 
and apical periodontitis lesions were recorded (134).  
 
Condylar movements were recorded by means of JLA and graded from 0 (normal movements) to 3 
(no movements). During analyses scores from 0 to 1 were classed as normal or mild and scores 
from 2 to 3 as marked. The JLA projections are one lateral image of the TMJ with the mouth in 
closed position and one image with the mouth in maximally open position. 
 
Examples of restricted movements of condyle in lateral panoramic tomographs for the three grades 
are given in Figures 5a – 5d. 
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Figure 5a-5d. Examples of the position of the condyle in the lateral panoramic radiograph view 
(mouth open). A, over or B, normal joint movement (1) C, light movement (2). D,  only light or no 
movement at all (3). 
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MRI of the TMJ was performed with a 1.5T scanner (Siemens Magnetom Vision, Siemens AG, 
Erlangen, Germany). A dedicated bilateral TMJ coil was used. Proton Density-weighted turbo spin 
echo, were used in sagittal and coronal cross-sections. T1-weighted slices with were 1.5 mm, thick, 
with a 2 mm interslices gap. T2-weighted slices with were 1.5 mm, thick, with a 3 mm interslices 
gap. The protocol for MRI interpretation included description of condyles and articular eminence 
morphology, translocation, assessment of disc position and bone marrow changes. Two radiologists 
(LK, PT) interpreted the images independently without knowing the clinical data or panoramic 
tomography findings and scored the erosions in condyles from 0 (no erosion or mild changes) to 1 
(clear erosion). The MR images were evaluated for disc morphology. Perforations were identified 
when there was abnormal disc structure where the disc was severely destroyed that only remnance 
or no disc structure at all could be seen (Figure 6). 
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Figure 6. a. A 50-year-old man with AS. Occasional subjective TMJ symptoms, maximal mouth 
opening 38 mm, pain and crepitation on palpation in right TMJ. MR image of TMJ in mouth closed 
position. The discus is totally destroyed and no disc material is visible There is well delineated 
erosion of the condyle (arrow head). 
 
 Figure 6. b. A 42-year-old woman with RA. Very sore TMJ muscles on palpation on both sides, 
maximal mouth opening 44 mm and crepitation on right side on palpation. MR image of TMJ in 
maximally opened position. The remnants of the disc are anteriorly luxated (arrow head) and 
translocation of the condyle is decreased. Note also the eroded and flattened condyle with an 
anterior hook formation. 
 
 
 
4.10 Statistics  
Data are given as means with standard deviations (SD) or as medians and interquartile ranges (IQR) 
when appropriate. Statistical significance was determined using the Mann-Whitney test, analysis of 
variance (ANOVA), the Kruskal-Wallis test, and the χ2-test when applicable. Odds ratios (OR) for 
the presence of focal sialadenitis and severe erosion in TMJ in panoramic radiograph and their 95% 
confidence intervals (95% CI) for different patient groups were analysed with a logistic regression 
model (NCSS 6.0, Statistical software, Kayswille, UT).  
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Significances of correlations were calculated using Spearman’s rank correlation test. A two-tailed p 
value below 0.05 was considered to indicate statistical significance. In the HLA frequencies, the 
corrected probablity (p) value (pc) was obtained by multiplying the p value by the number of HLA 
alleles tested (n=34) (Bonferroni correction). 
 
 
4.11 Ethics 
All subjects had given written informed consent to their participation in the study, and the Ethics 
Committee of Helsinki University Central Hospital had approved the study protocol.  
 
A panoramic radiograph that had been taken within the previous year had to be available for each 
control, because the Ethics Committee did not approve studies in which controls are subjected to X-
ray. Control group did not undergo minor salivary gland biopsy for ethical reason.  
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5 RESULTS 
 
5.1 Symptoms 
Information concerning smoking and dental care is shown in Table 11. 
Thirty-six patients had subjective oral symptoms (p=0.002). The symptoms were most frequent in 
MCTD (Table 12). Forty-five patients had ocular symptoms (13/25 patients with RA, 12/19 patients 
with MCTD, 10/19 patients with AS and 10/22 patients with SPA, p=0.73).  
 
The number of patients exhibiting severe TMJ symptoms was significantly higher than the number 
of the control subjects with such symptoms (p<0.001). The AS patients reported TMJ symptoms 
most often (7/19, 37%). TMJ clicking and crepitation were reported by the patients with rheumatic 
disease significantly more often than by the control subjects (data not shown). Decreased subjective 
mouth opening was reported by 40% of the patients, most frequently by those with AS. 
 
Table 11. Smoking and dental care habits. 
 Rheumatoid 
arthritis 
(N=15) 
Mixed 
connective 
tissue disease 
(N=10) 
Ankylosing 
spondylitis 
(N=13) 
Spondylo- 
arthropathy 
(N=12) 
Control 
subjects 
(N=67) 
No of smoking 
patients 
1 (7%) 2 (20%) 6 (46%) 3 (25%) 8 (12%) 
Use of sugar 
with tea/coffee 
7 (47%) 3 (30%) 7 (54%) 6 (50%) 22 (33%) 
Dentist visits/ 
year, mean (SD) 
1.2 (0.4) 1.5 (0.9) 1.5 (0.9) 1.5 (0.9) 1.2 (0.5) 
Brushig the 
teeth/day, 
mean (SD) 
1.9 (0.3) 1.9 (0.3) 1.9 (0.3) 2.0 (0.4) 2.0 (0.3) 
Use of the 
dental floss 
4 (27%) 4 (40%) 4 (31%) 4 (33%) 13 (20%) 
Use of the 
dental sticks 
12 (80%) 5 (50%) 8 (62%) 7 (58%) 36 (54%) 
Use of dental 
intermediate 
brushs 
2 (13%) 2 (20%) 2 (15%) 0 (0%) 0 (0%) 
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 5.2 Clinical findings 
Masticatory-muscle tenderness occurred significantly more often in the patients with rheumatic 
disease than in the control subjects (73% vs 30%, p<0.001). Tenderness of the masticatory muscles 
was observed frequently in all patient groups, with the lowest frequency (43%) in SPA patients 
(p=0.004 between patient groups) (Paper IV, Table 3, page 460).  
 
Values for maximum opening of the mouth (46.46mm (8.59) vs 55.0mm (7.4)) and maximum 
protrusion (5.23mm (2.78) vs 6.0 mm (2.0)) were significantly lower in the patients with rheumatic 
disease than in the control subjects (p<0.001 in each case). Decreased maximum mouth opening (≤ 
33 mm) was found in 6% (1/16) of RA, 0% (0/15) of MCTD, 17% (3/18) of AS and 11% (2/18) of 
SPA patients (NS). TMJ crepitation on clinical examination was common in all patient groups. 
Prevalences of laterotrusion, mediotrusion, protrusion and retrusion interferences did not differ 
between the groups of patients, or between the patient and control groups (NS). 
 
Decreased tear secretion occurred most often in patients with MCTD, and least often in SPA 
patients (χ2-test, p=0.021) (Table 13).  
 
There were no statistically significant differences in the number of patients with missing one or 
several teeth or clinically or radiographically detected caries lesions between the rheumatic patients 
and control subjects (Paper II, Table 2, page 5). The number of patients with CPI score 3 or 4 was 
significantly higher in rheumatic patients than in controls (p<0.0001) Severe periodontal disease 
was common in all patient groups being most prevalent in the RA group. In addition, abnormalities 
in oral mucosa were significantly more common in the rheumatic patients than controls (p=0.0002). 
Positive yeast count was significantly more common in the rheumatic patients than in the control 
subjects (p<0.001). 
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5.3 Saliva 
 
Salivary flow 
A statistically significant difference was observed in the number of patients with low resting 
salivary secretion rates (p=0.007) and stimulated salivary secretion rates (p<0.001) between the 
different patient groups and controls (Table 13). Decreased salivary secretion (either unstimulated 
or stimulated) was most frequently observed in patients with MCTD and least often in SPA patients 
(χ2-test, p<0.0001).  
 
The AS patients exhibited low resting salivary secretion rates significantly more often than the 
respective controls (22% [4/18] vs. 0% [0/18], respectively (p = 0.03). The MCTD patients had 
significantly more often reduced salivary flow both in the stimulated (40% [6/15] vs. 0% [0/15], p = 
0.0062) and resting values (60% [9/15] vs. 0% [0/15], p = 0.003) than the respective controls. Only 
eight patients and five controls used drugs known to affect salivary flow. However, all the patients 
who had taken such medication also exhibited other features of SS, such as focal sialadenitis and/or 
a positive result in Schirmer’s test. Salivary buffering capacities and pH values were similar in the 
patients and controls. 
 
Salivary composition 
The patients as a group had significantly lower salivary amylase concentrations (p<0.001), while 
albumin (p=0.0065), total protein (p<0.001), IgG (p<0.001) and IgM (p<0.001) concentrations were 
significantly higher than in controls (Table 14). Within the patient groups, concentrations of IgG 
and IgA were highest in the MCTD patients, the RA patients were characterized by significantly 
(p=0.005) lower salivary amylase concentrations. The MCTD patients had significantly higher 
salivary concentrations of total protein (p=0.0061), IgA (p=0.018), IgG (p=0.010), and IgM 
(p=0.0014). The AS patients had significantly higher salivary concentrations of total protein 
(p<0.001) and IgA (p=0.017) (Table 14). 
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 Relationship between serum and salivary immunoglobulin concentrations 
Serum IgA and IgG concentrations were significantly higher in the MCTD patients than in the other 
patients (p<0.001), while IgM concentrations did not differ significantly between the patient groups. 
Concentrations of serum IgG correlated significantly with salivary IgG concentrations (rs = 0.31, CI 
0.10 to 0.50) and serum IgM levels with salivary IgM levels (rs = 0.36, Cl 0.16 to 0.55). However, 
no significant correlation was observed between serum and salivary IgA concentrations. There was 
no statistically significant difference in the levels of serum IgA between the AS patients who had 
and who had not taken sulfasalazine medication (data not shown). 
 
5.4 Focal sialadenitis and secondary Sjögren’s Syndrome 
One biopsy sample (MCTD patient) was not representative and was therefore excluded from further 
analysis. Focal sialadenitis was observed in 68% (57/84) of all patients. It was most frequent in 
MCTD and least frequent in SPA patients (χ2-test, p = 0.0013). The median focus scores differed 
also significantly among the study groups, being highest (4.1) in the MCTD group and lowest (<1) 
in the SPA group (Kruskall-Wallis, p < 0.0001) (Figure 7). Compared to patients by whom salivary 
gland biopsy findings were normal, the patients with focal sialadenitis had more often reduced 
resting salivary flow rates (11/53 versus 1/24, p = 0.063) and stimulated salivary flow rates (12/53 
vs. 1/24, p=0.045). 
 
Patients with focal sialadenitis had more often both decreased salivary secretion (30 % vs. 4%; χ2-
test, p = 0.0074) and decreased tear secretion (58 % vs. 35%; χ2-test, p = 0.048) than had patients 
without it. Focus scores correlated negatively with the amount of both unstimulated and stimulated 
saliva secretion (Spearman rank correlation test, rs = -0.46, 95% CI -0.27 to -0.61; and rs = -0.51, 
95% CI -0.33 to -0.65, respectively).  
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Focal sialadenitis tended to occur more often in women (41/55) than in men (16/29) (χ2-test, p = 
0.071). In the multiple logistic regression model, increasing age and the MCTD group were 
independent risk factors for focal sialadenitis (Paper I, Table 4, page 747). No associations were 
observed between focal sialadenitis and the disease duration, the use of corticosteroids or 
sulfasalazine (data not shown). Significant correlations were found between focus scores and 
salivary concentrations of IgA (rs = 0.28, 95% CI 0.06 to 0.47), IgG (rs= 0.34, CI 0.13 to 0.52) and 
IgM (rs = 0.40, CI 0.19 to 0.67), and between focus scores and resting (rs = -0.45, 95% CI -0.61 to -
0.25) and stimulated salivary flow rates (rs = -0.49, 95% CI 0.64 to 0.30). 
 
According to the 1996 European diagnostic classification criteria of secondary SS (37) 28% (7/25) 
of RA, 73% (11/19) of MCTD, 26% (5/19) of AS and 15% (3/22) of SPA patients had a secondary 
SS (Table 13). 
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Figure 7.  The variation of focus score in various rheumatic diseases 
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Association between focal sialadenitis and laboratory parameters 
Patients with RF had significantly more often focal sialadenitis than had patients without it (χ2-test, 
p=0.002). Patients with focal sialadenitis had higher RF titers than those without it (Mann-Whitney, 
p<0.001). Similarly, patients with ANA, SSA-AB, or SSB-AB had more often sialadenitis than had 
patients without these antibodies (χ2-test, p=0.0041, 0.013, and 0.077, respectively). No 
associations were observed between focal sialadenitis and low complement levels or the presence of 
RNP or Sm antibodies. HCV antibodies were negative in all the patients tested.  
 
The subgroup of patients with AS or SPA was further analyzed for risk factors for sialadenitis. The 
presence of focal sialadenitis was not associated with decreased salivary or tear secretion, the 
clinical type of disease (axial or peripheral arthritis), age, the use of medication (corticosteroids or 
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sulfasalazine), the disease duration, presence of ANA, ENA, SSA-AB, SSB-AB, RNP-AB, Sm-AB, 
positive RF or low complement levels (data not shown). 
 
5.5 Radiology 
Distinct erosions were observed in four RA patients (17%), three MCTD patients (19%), seven AS 
patients (37%), eight SPA patients (38%) (Table 15) and one control subject (1%) (p<0.001). 
Patients with SPA had the most severe changes. The mean (range) erosion scores were 1.7 (0-4) for 
RA, 1.3 (0-3) for MCTD, 2.5 (0-4) for SPA, and 1.6 (0-4) for AS patients (p=0.04). 
 
Age and sex adjusted ORs (95%CI) for the presence of severe erosion in panoramic radiographs 
were 19.8 (1.95 to 2.01) for RA, 27.6 (2.45 to 311) for MCTD, 40.7 (4.41 to 375) for AS, and 42.5 
(4.79 to 377) for SPA patients as compared with control subjects. Restricted condylar movement 
was found in lateral panoramic radiographs relating to six RA patients (25%), five MCTD patients 
(31%), six AS patients (32%) and seven SPA patients (33%) (NS) (Table 15). Evidence of distinct 
erosion in a panoramic tomogram was significantly associated with evidence of restricted condylar 
movement in a lateral panoramic radiograph (p < 0.001). In the lateral panoramic radiographs 
restricted condylar movement was found in 25% (4/16) of RA, 13% (2/15) of MCTD, 33% (6/18) 
of AS and 28% (5/18) of SPA patients (NS). 
 
In MRI joint effusion was observed in one (6%) SPA patient. Erosions occurred in all groups, but 
were most frequent in RA patients, of whom 31% (5/16) showed these changes. Condylar 
osteophytes affected more than 60% of the patient groups studied (NS). Abnormal shape of the 
condyles was found in 27% of the patients. Osteophytes were observed in all groups, most 
frequently in RA patients and least often in SPA patients (NS). Joint space narrowing tended to be 
less frequent in SPA patients than in the other patient groups (p=0.093). 
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 Disc alterations were common in all patient groups and included perforation, anteriorly dislocated 
disc, and decreased movement (Table 15). Abnormal position of the discs occurred most often in 
RA patients and decreased movements most often in SPA patients. 
 
Correlations between clinical findings and MRI 
Reduced maximum mouth opening correlated significantly with the occurrence of disc perforation 
(normal, either side, both sides; rs = -0.51, 95% CI –0.67 to –0.30), decreased movement of the disc 
(-0.38, -0.48 to –0.02), osteoarthrosis (-0.47, -0.64 to –0.26), abnormal shape of the glenoid fossa (-
0.42, -0.60 to –0.20), abnormal shape of the condyle (-0.46, -0.63 to –0.24), and erosion of the 
condyle (-0.36, -0.56 to –0.13). The occurrence of TMJ crepitation on clinical examination was 
significantly associated with perforation of the disc (p<0.05 in the right side only), 
 decreased movement of the disc (p<0.05 in the right side only), joint space narrowing of the 
temporal surface of the TMJ (p<0.05 in the right side only), abnormal shape of the condyle (p<0.05 
both sides) and condylar osteophytes (p<0.05 both sides) in MRI. Tenderness of the masticatory 
muscles was significantly associated with condylar osteophytes (p<0.05 both sides). 
 
Pain in the TMJ during maximum mouth opening was associated with a flattened condyle (p=0.001 
for left side only). Pain in lateral movements was significantly associated with abnormal shape of 
the condyles (p<0.05 for both sides) and diminished thickness of the condylar cartilage (p<0.05 for 
both sides). No correlations were observed between deviated mouth opening and MRI findings. 
 
Panoramic tomography and MRI 
Severe condylar erosion (scale 3-4) in the panoramic radiographs was significantly associated with 
condylar erosion (p<0.01 for both sides), diminished thickness of the condylar cartilage (p<0.001 
for both sides), abnormal condylar shape (p<0.001 for both sides), and abnormal shape of the 
temporal surface of the TMJ (p<0.001 for both sides) in MRI. 
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In the lateral panoramic radiographs decreased movement was significantly associated with 
perforation of the disc seen in MRI (p<0.01 for both sides), abnormal anterior placement of the disc 
(p<0.005 for both sides), osteoarthritis of the condyles (p<0.05 for both sides), abnormal temporal 
surface of the TMJ (p<0.005 for both sides), abnormal shape of the condyle (p<0.005 for both 
sides) and diminished thickness of the condylar cartilage (p<0.05 for both sides).  
 
Association between clinical and radiographic findings 
In the patients with rheumatic diseases, subjective TMJ symptoms were commoner in patients with 
evidence of restricted movement in a lateral panoramic radiograph than in patients in whom lateral 
panoramic radiographs were normal (p<0.001). A similar association was also observed in the RA 
patients (p=0.043), MCTD patients (p<0.001) and AS patients (p=0.006) but not in the SPA 
patients. Among the more specific signs, clicking of a TMJ was associated with radiographic 
evidence of distinct erosion in the MCTD patients (p=0.007). TMJ crepitation was associated with 
radiographic evidence of distinct erosion in the AS patients (p=0.003). There was a significant 
inverse correlation between the movement of the condyle in the radiographs (graded as 0 to 3) and 
maximum clinical mouth opening in the patient groups (rs=-0.27, 95%CI –0.48 to –0.02, p = 0.034). 
Similarly, maximum mouth opening correlated inversely with the severity of erosion in panoramic 
radiographs (rs=-0.47, -0.64 to –0.25, p<0.001).  
 
Laterotrusion movement was significantly associated with radiographic evidence of distinct erosion 
in the entire group of patients (p < 0.001). Interferences were not associated with radiographic 
evidence of distinct erosion or with evidence of restricted movement in panoramic radiographs. 
In panoramic tomography the number of periapical lesions was significantly higher in the total 
rheumatic patient group than in controls (p=0.0015). 
 
 
 77 
5.6 HLA-associations 
HLA and diagnosis 
AS and SPA patients had a higher frequency of HLA-B27, and RA patients had a higher frequency 
of HLA-DRB1*04 than did control subjects. The frequencies of the other alleles which were typed 
did not deviate between any of the patient groups and controls (Table 16). 
 
Table 16. Frequencies of selected HLA alleles in the patient groups and control subjects. Results 
given as number of patients (percentage). 
___________________________________________________________________________ 
 
   RA (n = 24)  MCTD (n = 19)    AS (n = 19)  SPA (n = 22) Controls (n=100) 
___________________________________________________________________________ 
HLA-B27    6 (25%)   2 (10%)    18 (95%)*  20 (91%)*     14 (14%) 
 
HLA-DRB1*01  9 (38%)   8 (42%)    9 (47%)   11 (50%)       35 (35%) 
 
HLA-DRB1*04  15 (63%)**  2 (10%)    7 (21%)   4 (18%)         29 (29%) 
 
HLA-DRB1*06 3 (13%)        8 (42%)       5 (26%)       8 (8%)           23 (23%) 
 
HLA-DRB1*08 1 (13%)        5 (26%)           6 (32%)       9 (41%)         22 (22%) 
__________________________________________________________________________ 
*Pc = 0.0006 **Pc = 0.06 compared with control subjects 
 
HLA and TMJ erosion 
In the whole patient population, HLA-DRB1*01 was significantly associated with erosions in 
panoramic image: 16/36 (44%) of patients with HLA-DRB1*01 vs. 6/46 (13%) of patients without 
HLA-DRB1*01 had TMJ erosions (p = 0.0014; pc = 0.048). In the subgroup of patients with disease 
duration 10 year or lower, HLA-DRB1*01 was significantly associated with TMJ erosions (5/17 vs. 
2/22, p=0.031), when as in those patients with disease duration over 10 years this association tended 
to be statistically significant (11/19 vs. 4/15, p=0.069). This effect was mainly due to a high 
association in the SPA subgroup, where HLA-DRB1*01 carried a significant risk for erosions: 8/10 
(80%) of HLA-DRB1*01 positive patients vs. 0/11 (0%) of HLA-DRB1*01 negative patients had 
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erosions (p=0.0002; pc=0.0068). DRB1*06 was protective against erosion: 0/8 (0%) of SPA 
patients with this allele showed erosive findings vs. 8/13 (62%) of patients without this allele 
(p=0.018; pc=0.061).  
 
HLA and oral and salivary findings 
When all patients were analysed as a group, the presence of focal sialadenitis was significantly 
associated with HLA-DRB1*03 (presence of sialadenitis in 12/12 [100%] in HLA-DRB1*03 
positive patients vs. 45/70 [64%] in HLA-DRB1*03 negative patients, p = 0.013), while HLA-
DRB1*08 was slightly protective (10/20 [50%] vs. 47/62 [76%], p = 0.029). 
 
RA patients with HLA-DRB1*04 had more often increased salivary IgG (8/16, 50%) compared 
with HLA-DRB1*04 negative patients (1/8, 13%) (p = 0.074). A reverse trend with respect to IgA 
was observed in AS patients: 1/7 (14%) of patients with HLA-DRB1*04 had elevated salivary IgA 
compared with 6/11 (55%) of patients without HLA-DRB1*04 (p=0.088).  
 
No associations were observed between HLA alleles and salivary total protein, amylase, IgM, or 
albumin concentrations (data not shown). Neither were associations found between the presence of 
periapical infection foci and the HLA alleles (data not shown).  
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6. DISCUSSION 
6.1 Validity of the data 
In the study reported here routine examination protocols and methods were used generally accepted 
in stomatognathic physiology. 
The rheumatic patients, with or without TMJ problems, were consecutive patients from the 
Outpatient Department of Rheumatology. All patients were examined at the same time by only one 
person using the same material and methods. It is possible that medication may have influenced the 
results of salivary or tear secretion, but this was carefully recorded. The use of sulfasalazine and 
corticosteroids had no effect on the occurrence of focal sialadenitis within each of the study groups. 
Salivary gland biopsies of the lower lip were taken in a standardized way. All of the biopsies were 
representative except one, which was excluded. The labial salivary gland biopsy procedure 
described here is safe and effective, provided that the biopsy is performed through clinically normal 
mucosa. The specimen should contain enough separate glands for interpretation, and the 
histopathologic examination includes determining a focus score. Focal sialadenitis in an adequate 
labial salivary gland specimen is said to have a good specificity and sensitivity for SS when the 
focus score is at least one (128). However, patients with SS can have normal focus score with 
advanced disease (136) or focal sialadenitis with normal salivary flow disease (136) indicating a 
low specificity and sensitivity of the histology in the diagnosis of SS. 
 
Conventional radiographic methods have been used to demonstrate TMJ abnormalities in series of 
patients with RA (37, 138-140), AS (37, 140, 141) and psoriatic arthropathy (37, 139-142). The 
panoramic radiographs were examined by two investigators blinded to the clinical characteristics of 
the patients. In borderline cases the more conservative option was chosen. We used an arbitrary 
scale with five grades.  
MRI has proved valuable in the assessment of the TMJ in patients with rheumatic diseases (37, 120, 
121). In addition to joint effusion and bony abnormalities, various stages of disc destruction have 
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been shown to be indirect signs of synovial membrane proliferation and pannus formation (37, 120, 
121). It has, however, been difficult to identify the thickened synovium itself, indicating that 
conventional MRI without gadolinium enhancement is limited in depicting early changes of 
rheumatic TMJ disease (114). Our results on chronic patients are in agreement with this. 
 
6.2 Focal sialadenitis 
Focal sialadenitis was common in patients with various rheumatic diseases, being most common in 
the MCTD patients But surprisingly it was also common in the AS and SPA patients. The presence 
of secondary SS was also high in all study groups. Focal sialadenitis was significantly associated 
with decreased salivary and tear secretion. Significant associations were observed between focal 
sialadenitis and RF and its titer; and the presence of ANA, and SSA and SSB antibodies. This 
observation was confined to the RA and MCTD patient group. Increasing age and MCTD were 
independent factors for focal sialadenitis. There was also a correlation between the HLA allele and 
focal sialadenitis. 
 
Our results confirm previous findings on the high prevalence of focal sialadenitis and decreased 
salivary excretion in MCTD patients (19, 142) (Paper I, Table 2, page 746). Konttinen et al. (19) 
observed focal sialadenitis in nine and decreased salivary excretion in seven out of ten MCTD 
patients. These are comparable with the 94 % and 61% prevalence rates, respectively, that was 
observed in our 18 MCTD patients. In the present study, 80 % of the RA patients had focal 
sialadenitis, and 40% had sialadenitis combined with decreased salivary or tear secretion. These 
figures are higher than those by Andonopoulos et al. (3) who found focal sialadenitis in 31% and 
sialadenitis combined with clinical manifestations of SS in 24% of RA patients. The difference can 
be explained by the scoring systems. 
 
 Andonopoulos et al (3) used Tarpley’s classification (143) from 1974, which accepts higher 
number of inflammatory cell aggregates as pathological compared with the presently widely used 
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scoring system applied by us. In agreement with previous literature (3,19,143), the focus scores in 
our patients with focal sialadenitis in association with MCTD or RA were distinctly abnormal. This 
contrasts with the minor increase in the scores in patients with AS or SPA. Thus, while abnormal 
scores occurred in all the patient groups, patients with MCTD or RA differed distinctly from those 
with AS or SPA. 
 
A few studies have investigated the occurrence of focal sialadenitis in patients with AS or SPA 
(144,145). In the present study, 58% of the AS and 41% of the SPA patients had focal sialadenitis 
(Paper I, Table 2, page 746). Whaley et al. (146) observed a distinct (grade III) focal sialadenitis in 
two out of twelve AS patients, of which neither had decreased salivary or tear secretion. Brandt et 
al. (71) found also a definite focal sialadenitis (focus scores from 2 to 13) in seven (7%) out of 105 
SPA or AS patients. However, Brandt et al. (71) collected biopsies only from patients, who had a 
combination of both symptoms of dry mouth and/or eyes and positive ANA antibodies. The 
differences in the higher frequencies of focal sialadenitis between the present study compared with 
the low figures by Whaley et al. (146) and Brandt et al. (71) can be explained by the different 
criteria for the definition of abnormal focus score. We have accepted all patients with the focus 
score of >1, as suggested by the European classification criteria 1996 (7). Despite the high 
occurrence of focal sialadenitis in the SPA group, none showed decreased salivary secretion, and 
the median focus score was quite low, suggesting that the severity of sialadenitis was mild in this 
group. However, 23 % of the SPA patients had decreased tear secretion. The moderately increased 
focus scores observed in AS and SPA may be an indicator of mild sialadenitis. They can be also 
interpreted as reflecting poor specificity of focus scores, because of the low association with clinical 
findings (146, 147). 
 
 On the other hand, the focus score can be increased prior to the development of oral symptoms 
(148), indicating a need for follow-up of the patients with abnormal focus score in the present study. 
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In the normal population, both tear secretion and salivary secretion are physiologically reduced in 
the elderly (149). Vitali et al. (128) found that the presence of inflammatory foci in lip biopsies of 
patients without Sjögren’s syndrome did not correlate with age, whereas Syrjänen (146) observed 
that foci of inflammatory cells increased with ageing, as well as with acinar atrophy, ductal 
dilatation, and degree of fibrosis, among 78 healthy individuals. Disease duration did not correlate 
with focal sialadenitis in the present study, which is in accordance of the findings of Gerli et al. 
(147). 
 
In patients with RA, the presence of ANA was observed in 44%, a figure comparable to that in the 
literature (150), while SSA/SSB antibodies were not present in RA. SSA/SSB antibodies are most 
common in patients with primary SS and SLE (151, 145) but occur infequently in patients with RA 
(57) (Paper I, Table 1, page 745). In accordance with previous reports (152), we observed SSA/SSB 
antibodies in 58% of the patients with MCTD. We used immunodiffusion to measure these 
antibodies. Immunodiffusion is less sensitive than ELISA to detect SSA and SSB antibodies (152). 
Immunodiffusion detected these antibodies only in 0-2 % of RA patients, while the frequency was 
22-28 % when measured by ELISA (152, 155). The antibody levels have been shown to change in 
association with changes in the disease activity of patients with SS and SLE (154). The absence of 
SSA and SSB antibodies is a further evidence in favour of poor agreement between histology and 
autoantibodies as discussed previously (155). 
 
In accordance with the findings of Saito et al. (155), we observed an association between the 
presence of RF, ANA, SSA-ab or SSB-ab and focal sialadenitis in labial salivary gland biopsies. 
Patients with focal sialadenitis also had higher titers of RF than had patients without sialadenitis. 
Shah et al. (152) and Gerli et al. (147) also found significant associations between focal sialadenitis 
in labial salivary gland biopsies and the presence of ANA, SSA, and SSB antibodies. An 
autoimmune focal sialadenitis, as confirmed by high focus scores in labial salivary gland biopsies 
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 in the present study, seems to be the most likely reason for decreased salivary secretion in patients 
with MCTD or RA. 
 
6.3 Oral health and saliva 
In primary SS incidences of caries and changes in the oral mucosa are relatively high (80, 87, 146). 
There is an increasing risk for oral and dental infections, when salivary flow is decreased. However, 
in most studies SS does not appear to increase the risk of periodontal disease (87, 88). But there is a 
good evidence to suggest that individuals with moderate to severe periodontal disease are at higher 
risk of suffering from RA and vice versa (10, 11). 
 
In the present study periodontal disease commonly affected all rheumatic diseases, also patients 
with seronegative arthritides (Paper II, Table 2, page 5). Fifty-six per cent of AS and 45% of SPA 
patients showed a CPI score of 3-4 indicating serious periodontal condition. The presence of 
secondary SS was not a risk for periodontal disease in our study (Paper II, Table 6, page 7). 
Konttinen et al. (19) studied 10 patients with MCTD: All dentulous patients (8/10) had pathological 
gingival pockets (CPI score 3 or 4), two patients showed fungal growth, and four had abnormalities 
in oral mucousa. In the present study, 53% of the MCTD patients had periodontal disease, 98% had 
positive yeast count, and 20% mucosal alterations. Similarly the rheumatic patients had slightly 
higher number of missing teeth per patient than among controls. 
 
Patients with MCTD had low salivary flow rates, high concentrations of salivary IgG and IgA that 
differed most from those in the controls, but salivary flow rates were also low in the AS patients. In 
the saliva samples from the patients concentrations of amylase were lower while concentrations of 
total protein, albumin, IgA, IgM, and IgG were higher than those of controls.  
 
Salivary secretion rates correlated negatively with lip-biopsy focus scores. A close correlation 
between minor salivary gland inflammation and whole salivary secretion has also been observed. 
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Similar to the situation in other organs, the salivary glands can compensate functionally for modest 
loss of parenchyma. In the early stages of disease, stimulated flow rates may therefore be normal or 
only slightly reduced. In later stages, however, there is a much greater loss of tissue and stimulated 
flow rates may be significantly reduced. AS patients may therefore experience subclinical minor 
salivary gland inflammation associated with low resting salivary secretion rates while MCTD 
patients may exhibit long-standing sialadenitis resulting in decreased secretion from the larger 
salivary glands. To confirm this, however, further studies are needed.  
 
Amylase is the most important digestive enzyme in saliva, and a major component of parotid saliva. 
Amylase concentration is a marker of protein synthesis in the acinar cell (73). The patients had 
lower concentrations of salivary amylase than controls (Paper II, Table 4, page 6). This finding was 
most pronounced in the RA and MCTD patients indicating impaired functioning of the salivary 
gland acini in these individuals. Focal sialadenitis was more frequently observed in these groups 
than in the AS or SPA patients (Paper II, Table 3, page 6). In contrast to our observations van der 
Reijden et al. have reported that concentrations of salivary amylase in cases of secondary SS were 
similar to those in controls.  
 
Elkon et al.(75) found that salivary IgA concentrations were higher in RA patients with dry eyes 
than in control subjects and that even RA patients without dry eyes had high concentrations of 
salivary IgG. High levels of IgA, IgG, and IgM have also been reported in whole saliva from 
patients with secondary SS (75, 78). In a normal population, concentration of IgA in saliva is 
inversely related to salivary flow rate. Stimulating flow results in dilution of IgA both in the parotid 
and whole saliva (78). Salivary IgA, IgG, and IgM concentrations were significantly higher in 
patients with rheumatic disease than in controls. Particularly high concentrations of both IgA and 
IgG in saliva were observed in the MCTD patients. In line with our findings, Ben-Aryeh et al. (80) 
have suggested a positive correlation between focus score and salivary IgA concentration. The 
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increases in salivary IgA and IgG concentrations detected in primary and secondary cases of SS 
could result from massive infiltration of salivary glands by B cells, or leakage from serum into  
the damaged glands (81). High numbers of IgG-producing plasma cells have been observed in 
lymphocytic infiltrates of minor salivary gland biopsy specimens in patients with secondary SS 
(82). High serum IgA concentrations are characteristic in active AS (83). It has been suggested that 
it results from stimulation of the gut immune system by Gram-negative bacteria in the gut (83). Use 
of sulfasalazine by patients with active AS has been shown to restore the levels to normal of IgA in 
serum (82) and of secretory IgA in the gut (84). However, in the our study no significant differences 
were seen between serum and salivary levels of IgA in the AS patients with respect to current 
consumption of sulfasalazine. 
 
The patients had significantly higher concentrations of salivary albumin, a marker of plasma 
ultrafiltrate. This finding was most marked in the AS patients. The high levels of salivary albumin 
may indicate decreased mucosal integrity in the oral cavity, like what is seen in the gut of AS 
patients (78, 83). High salivary albumin concentrations have previously been reported in RA, SS 
and control subjects (76) and, for example, in patients treated for lymphoma (134). 
 
6.4 HLA-alleles 
MacGregor et al. (157) have investigated the association between allotypes of HLA-DR4 and 
radiological erosion in the peripheral joints of patients with RA. They found that in all patients with 
RA, DRB1*0401/0404 genotype was associated with a substantially increased risk of being 
rheumatoid factor positive, and of having subcutaneous nodules and radiological erosion. They 
suggested that HLA-DRB1*04 might be a marker of severe RA. However, in previous studies from 
Finland by Möttönen et al. (34) such an association was not observed.  
 
The association between HLA-antigens and TMJ erosion has not been studied earlier. Our results 
showed that instead of HLA-DRB1*04, HLA-DRB1*01 was significantly associated with distinct 
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erosions in the TMJ in patients with rheumatic diseases (Paper II, results, page 26). In the subgroup 
of SPA patients, HLA-DRB1*01 carried a high risk for erosion, whereas DRB1*06 provided 
protection against it. This is in agreement with a recent report by Henry et al. (158) where internal 
derangement with severe TMJ symptoms in patients with various diseases were associated with 
HLA-DR1 and HLA-DR4. While our patients were collected from normal routine outpatient clinic, 
it is interesting that the genetic markers turned out to be the same as in the highly selected patients 
with severe TMJ disorders (158).  
 
HLA-DRB1*04 was associated with increased salivary concentrations of IgG in the RA patients, 
while in AS patients, HLA-DRB1*04 was protective against increase in salivary IgA. We also 
observed a significant association between HLA-alleles and the presence of focal sialadenitis. 
While previous studies have presented evidence to genetic associations with immunological 
aberrations in both primary (159-160) and secondary (159-160) SS, we saw here evidence that the 
development of focal sialadenitis, as a feature of secondary SS, in patients with a wide spectrum of 
arthritides would be genetically determined. 
 
6.5 Temporomandibular disorders 
Patients suffering from the various rheumatic diseases exhibited higher prevalences of 
stomatognathic problems and radiographic evidence of TMJ destruction than the matched controls. 
The patients with MCTD exhibited lower prevalences of individual symptoms, abnormal findings 
on examination and erosions than the other patients. There were no major differences between the 
other groups of patients. 
 
In previous studies, prevalences of clinically evident TMJ involvement in patients with RA have 
been reported to be between 2% and 98% (118). Results of most studies indicate that more than 
50% of patients with RA exhibit clinically evident TMJ involvement (16,161). The prevalence of 
TMJ involvement in patients with AS has been found to range from 4% to 35%, depending on the 
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diagnostic criteria used, the population studied and the means employed to assess TMJ involvement 
(118, 125). 
 
 Crum and Loiselle (166) reported that 16% of patients with AS complained of pain and tenderness 
in the TMJ region, with limited jaw opening. Davidson et al. (125) reported that 10% of patients 
with AS exhibited restricted jaw opening. Ramos-Remus et al. (126) studied 65 AS patients and 22 
control subjects. They found TMJ involvement to be common in the AS patients and associated 
with findings suggestive of more severe disease. Könönen et al. (117) have also reported that 
clinical signs of temporomandibular dysfunction are common in patients with RA, psoriatic arthritis 
and AS. 
 
The patients in this study reported often sounds, pain, stiffness, and restricted condylar movement. 
They also complained of headache more often than the controls. Pain in the preauricular area is 
common, and often experienced as ear pain (90) (Paper IV, Table 2, page 457). The patients studied 
also reported auricular pain more often than the controls. It has been suggested that compression of 
retrodiscal tissue, in the bilaminar zone, may be the cause of such pain. Other suggested causes are 
inflammatory change secondary to internal derangement, stretching of the joint capsule and 
synovitis. Inflammation could explain the high prevalence of TMJ symptoms in our patients 
because the control subjects exhibited much lower prevalences of various symptoms. Another 
important source of pain is disorder of the masticatory muscles. If a joint is not functioning 
normally a patient will often develop muscle tenderness that can be experienced as facial pain. This 
was noted in the study described here, and has been recorded earlier by Könönen (117). It is often 
difficult to distinguish between muscle and joint pain on physical examination (90). Tenderness of 
the masticatory muscles in a patient with rheumatic disease is therefore a good indicator of TMJ 
inflammation. This is particularly true for inflamatory arthritis and other autoimmune diseases 
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where the muscles may also have a low grade inflamation (162). It could also reflect the existence 
of permanent TMJ destruction.  
 
Other suggested causes of TMJ disorders are direct facial trauma. A history of facial trauma was 
reported by 12-25 % of the patients in our study and by 26% of the control subjects. However, 37% 
of the AS patients reported a history of facial trauma. Results of some studies suggest that TMJ 
abnormalities can result in changes in dental occlusion (117). In this study, an association between 
lateral excursion movement and erosion of the TMJ was found (Paper IV, Table 5, page 461). This 
was also in agreement with Könönen (117) who found no correlation between any dental factor 
studied and clinical signs of stomatognathic disorders. No statistically significant differences were 
found between the groups of patients and the controls in relation to prevalence of interference, 
confirming previous findings (117). 
 
6.6 Radiology  
Results of most studies indicate that the prevalence of radiographically evident TMJ abnormalities 
ranges from 50% to 80% in RA patients (16, 163, 164). In another study, Wenneberg et al. found 
panoramic radiographic changes more frequently in patients with RA (66%), psoriatic arthritis 
(38%) and AS (30%) than in controls (12%) (163). In AS patients Wenneberg and Kopp (17) also 
observed a good correlation between subjective symptoms and extent of radiological changes to the 
TMJ. Wenneberg et al. (165) found radiographic erosions of TMJ in 56% of RA and 18% of AS 
patients, and in 1% of control subjects. RA patients showed also commonly flattening of condyles, 
subcortical cysts and cortical sclerosis. Konttinen et al. (19) observed radiographic TMJ changes in 
seven out of ten MCTD patients, four of them with erosions. Locher et al. (166) found erosions of 
the TMJ in 20% of AS patients. There are only a few studies relating to SPA patients other than 
those with psoriatic arthropathy. In a recent study, it was found that patients with Reiter’s disease 
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frequently exhibited TMJ symptoms and that 33% had erosions (164). These figures correspond 
fairly well with ours, although the occurrence of erosions in the TMJ was much lower in our RA 
patients (21%). The occurrence of TMJ erosions was highest among patients with HLA-B27 
associated diseases (AS and SPA), and considerably higher than that reported by Wenneberg et al. 
(164). 
 
In addition to standard TMJ radiography, panoramic and lateral panoramic radiography can be 
valuable in the initial screening for osseous abnormalities such as fractures and advanced 
degenerative joint disease. Such radiography can also be used to study inflammatory TMJ changes 
(90). Wenneberg et al. (163,167) used panoramic radiography to compare 90 patients with AS with 
age- and sex-matched controls. Radiographic changes were observed in 25% of patients and 11% of 
controls. In our study, we observed a high prevalence of erosion in both the AS and SPA patients 
but in only 1% of the controls. Despite the differences between the patients in our study and that of 
Wenneberg et al. (164) the associations between clinical findings (tenderness of the masticatory 
muscles and deviations in mouth opening) and radiographic TMJ erosions are very similar. We also 
found that abnormal opening of the mouth correlated with joint destruction as measured using 
lateral panoramic radiographs. Clinical examination would therefore seem to be a suitable method 
for screening patients for further examination and treatment of TMJ dysfunction. 
 
In the only study, on MCTD patients, reported in the literature, radiographic TMJ changes were 
found in seven out of 10 instances (19). Erosion of the condyle similar to changes seen in RA 
patients was noted in four of 10 MCTD patients (19). Limited condylar function was noted  in only 
one of the latter patients there was (19). Our findings are in accordance with those by Konttinen et 
al. (19). MCTD is a disease in which clinical features vary considerably between patients, and with 
time. Some patients end up with erosive peripheral arthritis (123). A high prevalence of TMJ 
changes was therefore to be expected.  
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It has been reported that in a patient with unilateral symptoms an asymptomatic contralateral joint 
often shows signs of internal derangement during clinical and radiographic examinations (167-169). 
These studies employed a variety of methods in addition to tomography. 
 
 Although complete condylar destruction or evident bone erosion at different locations within the 
joint may be considered typical of rheumatic disease involving the TMJ, the bone abnormalities 
may also be quite similar to those found in degenerative joint disease. Therefore, in previously 
reported series of rheumatic patients with TMJ problems it may not necessarily have been the 
results of the rheumatic process that were described (141). 
 
6.7 MRI 
In this study MRI images were evaluated for condyle and disk morphology and position (Table14) 
(Paper V). MRI of the TMJ allows direct visualisation of the disc before and after treatment (2). 
Perforations were identified when there was abnormal disk structure where the disk was severely 
destroyed that only remnance or no disc structure at all could be seen. The use of a contrast medium 
e.g. gadopentetate dimeglumine would have improved the detection of these perforations. However, 
the use of this contrast was not available at the time of the study. The use of CT-scan would have no 
doubt rendered better diagnostic results to identify bony erosions (170, 171). However, the risk of 
unnecessary exposure to high doses of radiation limited our choices when planned this study. The 
use of MRI is a non invasive alternative method compared to CT-scan. MRI is also better in 
showing the soft tissue damages, which is important in imaging patients with rheumatic diseases 
(16,168).   
  
A good correlation between clinical symptoms and TMJ changes by imaging was observed. The 
association between clinical signs and symptoms of temporomandibular diseases and radiographic 
findings of the TMJ has been widely discussed, and conflicting results have been presented 
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(169,161). In epidemiological studies on adult populations, tenderness to palpation of the TMJ has 
been found in 10-45% of patients examined (170, 172). In patients with TMD, tenderness in the 
TMJ has been recorded in up to 75% of all patients examined (174).  
 
Ramos-Remus et al. (172) studied 11 AS patients with severe cervical spine involvement. TMD 
were reported by seven of the patients and ten had abnormalities on MRI of which six were 
classified as grossly abnormal. In this study the clinical disease of 18 AS patients was less severe. 
Thus, the observed MRI findings were also mild to moderate. 
 
Larheim et al. (37) studied 28 symptomatic patients with rheumatic diseases (21 with RA, four with 
psoriatic arthropathies, two with AS and one with Reiter’s disease). MRI showed bony 
abnormalities in 27 of the 36 TMJs studied. The reported abnormalities included joint effusion, disc 
abnormalities, and condylar degenerative findings. The occurrence and findings were well in 
accordance with the present study for RA patients. 
 
In the present study, both SPA and MCTD patients commonly showed articular, disc and bony 
abnormalities in MRI, although these findings were less frequent and usually also less severe than 
in RA and AS patients. However, MCTD patients frequently showed condylar osteophytes (60%), 
joint space narrowing (93%), and perforation of the disc.  
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7. CONCLUSIONS 
 
1. Focal sialadenitis affects a high proportion of MCTD, RA, AS, and SPA patients. Its occurrence 
is significantly associated with RF, as well as with ANA, SS-A and SS-B antibodies. The 
association is most evident in RA and in MCTD. Because of the common problems in all the 
patient groups, the patients should be screened for ocular and oral symptoms and if 
symptomatic, should be referred to specialist care. 
 
2. Signs of periodontal disease, and abnormalities in salivary flow and composition, were all more 
common in patients with rheumatic diseases as compared to healthy control subjects. 
 
3. Pain, crepitation and decreased condylar movement were frequent clinical findings in the patient 
groups. The presence of these findings in Rheumatoid patients indicates the need for 
radiography (panoramic tomography and lateral panoramic tomography), which is usually 
sufficient to show rheumatic changes. There was a good correlation between panoramic 
radiographs and MRI. MRI was able to demonstrate articular cartilage changes, disc 
abnormalities and joint effusion. Thus, if panoramic radiographs in a symptomatic patient with 
rheumatic diseases are within normal limits, MRI can provide valuable additional information 
about the TMJ. MRI can be useful when planning a surgical intervention of the disc or synovial 
membrane. In addition, in a patient with acute arthritis and symptoms of TMJ, MRI could also 
be used to detect acute joint inflammation. 
 
4. HLA-DRB01 alleles was associated with distinct radiographic erosions in the TMJ. HLA-
DRB01*03 alleles was associated with the presence of focal sialadenitis, as well as increased 
concentrations of salivary immunoglobulins. Genetic background may contribute to the 
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development of TMJ erosions and is involved in salivary composition in patients with various 
rheumatic diseases. HLA-DRB1*01 antigen seemed to have an impact on the development of 
erosions in TMJ and especially in patients with spondyloarthropathies. 
 
5. The prevalence for TMJ involvement in rheumatic patients varies from 0-75% based on 
radiological changes and depends on the type of rheumatic diseases. It is important for dentists 
to follow-up dental occlusion and TMJ disorders and to compare the disease activity in all 
rheumatic patients. 
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APPENDIX 
 
1. Personal data (ID, adress, telephone number…) 
2. Medication 
3. Allergy 
4. Questions 
• Sounds from the TMJ (ie. clicking, crepitation)?  
• Tiredness of jaw? 
• Do you feel pain in the TMJ area and TMJ, when opening mouth as wide as you can (maximum 
opening)? 
• Difficulties opening the mouth? 
• Pain in the TMJ area and TMJ? 
• Do you feel (or have you felt) pain or tiredness in jaws when chewing food or gum? 
•  Other different feelings in TMJ and jaw area? If yes, what? 
• Contiquous headache? 
• Ear problems? If yes, what? 
• Eye problems? If yes, other questions were asked: 
-     Have you had daily: persistent, troublesome dry eyes? 
-     Do you have a recurrent sensation of sand or gravel in the eyes? 
-     Do you use tear substitutes? 
• Oral symptoms? If yes, other questions were asked: 
-     Have you had a daily feeling of dry mouth? 
-     Do you frequently drink liquids to aid in swallowing dry food? 
• Habbits: 
- Bruxism 
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- Clenching of teeth 
- chin or lip biting 
-     nail biting 
-      biting of pensil or something like that? 
• Do you feel (or have you felt) pain temporal area? 
• Have you ever get any hit to the face? 
• How do you describe problems in the TMJ and jaws? 
0=  no problems at all 
1=  very light problems 
2=  light problems  
3=  moderate problems 
4=  nearly difficult problems 
5=  very difficult problems 

